[
    {
        "pmid": "40815785",
        "title": "Willingness to Pay for the COVID-19 Vaccine and Its Correlates in Bangladesh: Cross-Sectional Study.",
        "abstract": "Government Bangladesh offer COVID19 vaccine cost however sustaining free vaccination program large population pose significant challenges Thus assessing willingness pay WTP COVID19 vaccine essential understanding potential pricing strategies subsidy requirements vaccine demand study aimed assess prevalence WTP COVID19 vaccine correlates crosssectional design used collect data 1497 respondent webbased platform facetoface interviews Multivariable logistic regression used analyze correlate WTP result showed 772 1497 516 participant willing pay COVID19 vaccine median 300 BDT IQR 150500 BDT currency exchange rate 1 BDTUS 0008 applicable WTP significantly higher among individual graduate degree adjusted odds ratio aOR 198 95 CI 114345 masters MPhil PhDlevel education aOR 193 95 CI 107348 higher knowledge vaccine aOR 109 95 CI 102115 positive behavioral practice aOR 111 95 CI 106117 stronger subjective norm regarding COVID19 vaccine aOR 125 95 CI 108146 higher anticipated regret getting infected COVID19 aOR 117 95 CI 104132 Conversely WTP lower among participant negative attitude toward vaccine aOR 091 95 CI 088095 high perceived behavioral control regarding COVID19 vaccination aOR 086 95 CI 076096 P006 nearly half respondent unwilling pay study highlight need improve vaccinerelated knowledge enhance incomebased affordability increase WTP Health promotion effort focus disseminating knowledge vaccine addressing negative perceptions Additionally subsidized program lowincome group help mitigate financial barrier promote equitable access vaccines",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815785/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40813708",
        "title": "One Health investigation of the first human rabies death linked to a clinically suspected rabid bull calf in Bangladesh.",
        "abstract": "Rabies fatal neglected zoonotic disease remains endemic Bangladesh human case result dog bites uncommon livestock bitten dogs report present first known clinically diagnosed human rabies case Bangladesh associated exposure infected livestock case involved 65yearold male farmer rural Bangladesh died clinically diagnosed rabies minor unrecognized exposure bull calf suspected rabies man suffered little hand injury feeding calf showing progressive neurological symptom consistent rabies Despite medical advice receive postexposure prophylaxis PEP largely due negligence Thirtyfour day exposure man began exhibit early symptom rabies including limb weakness neck back pain anxiety early sign hydrophobia illness quickly progressed classic feature furious rabies severe hydrophobia aerophobia confusion agitation died 41 day initial exposure case triggered fear panic local community reflecting broader lack awareness rabies particularly transmission nontraditional host like livestock incident highlight severe consequence inadequate awareness delayed missed PEP following potential rabies exposure emphasizes urgent need raise public awareness possible transmission routes ensure timely access PEP human animals stray dog vaccination strengthen publicveterinary health collaboration Bangladesh",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813708/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40791273",
        "title": "Childhood diarrhoeal disease in South Asian countries: a population-based analysis.",
        "abstract": "Despite advancement water sanitation vaccination childhood diarrhoeal disease CDDs continue pose significant public health challenges especially South Asia study aim estimate pooled prevalence CDDs South Asia identify key factor contributing persistence providing crucial insight future policy intervention strategies study utilised data recent Demographic Health Surveys conducted 2015 2022 Afghanistan Bangladesh India Nepal Maldives Pakistan focusing child 5 year old Descriptive statistic used measure prevalence CDDs multivariable logistic regression performed identify significant factors p value 005 considered level significance overall pooled prevalence CDDs 1013 95 CI 983 1045 Afghanistan highest rate childhood diarrhoea South Asian region prevalence 2915 95 CI 2801 3031 Maldives lowest prevalence 417 95 CI 320 542 Higher odds CDDs associated younger children male sex younger mothers mother little education larger households unimproved drinking water type toilet facilities lack access antimicrobial agent handwashing limited electronic medium access However factor varied country country study highlight persistently high prevalence childhood diarrhoea South Asia Countryspecific finding underscore urgency focused interventions particularly Afghanistan Pakistan effectively reduce CDDs region",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791273/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40790080",
        "title": "Genetic diversity analysis of IVM resistant Haemonchus contortus in sheep in inner Mongolia of China.",
        "abstract": "Haemonchus contortus widely distributed world seriously harmful small ruminant serious resistance common anthelmintics time prevalence intensity host infection parasite gradually increased necessary study phylogenetic genetic change single anthelmintic resistant strains study first analyze genetic diversity population structure IVMresistant Hcontortus L3egg adult n  30  Inner Mongolia China Hcontortus identified IVM resistance cultured fecal egg count reduction test larval development inhibition test larval locomotor behaviour test complete sequence ITS2  second internal transcribed spacer  partial sequence nad4  nicotinamide dehydrogenase subunit 4 gene  L3 adult egg amplified time compared ITS2 nad4 partial sequence Hcontortus reported NCBI database carry phylogenetic analysis haplotype determination study variation population genetic diversity IVMRR samples sample identified Hcontortus resistant IVM Phylogenetic analysis ITS2 IVMRR Hcontortus showed branch genetic relationship close intraspecific relatively conserved significant correlation AR significant difference different stage development samples addition 30 nad4 gene sequence IVMRR sample obtained 13 haplotypes 169th base site 70 nad4 gene mutated nucleotide diversity 000623 haplotype diversity 0926 IVMRR compared five countries Hcontortus nad4 found genetic differentiation level IVMRR population relatively low China Pakistan populations Fixation index Fst 010957 017262 respectively genetic differentiation level Bangladesh Greece France population higher Fst value 046978061825 098101 Perhaps population structure differentiation correlated regional localization anthelmintic frequency treatment report analyzed genetic diversity population differentiation IVM resistant Hcontortus different developmental stages obtained resistant samples haplotypes hoping provide new direction study AR vaccine research",
        "mesh_terms": [
            "Animals",
            "Haemonchus",
            "Genetic Variation",
            "Sheep",
            "China",
            "Phylogeny",
            "Drug Resistance",
            "Haemonchiasis",
            "Anthelmintics",
            "Haplotypes",
            "Sheep Diseases",
            "Ivermectin"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790080/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40784902",
        "title": "Dengue fever in Bangladesh: rising trends, contributing factors, and public health implications.",
        "abstract": "Dengue fever emerged major public health crisis Bangladesh unprecedented surge case fatality recent years paper analyzed epidemiological trends contributing factors public health implication rising dengue burden country Surveillance data revealed staggering 203406 dengue case 989 death January September 2023 marking 19fold increase compared entire year 2019 capital bear brunt outbreak account half case deaths Climatic factors rapid urbanization population density insecticide resistance lack public awareness created perfect storm dengue transmission overburdened healthcare system struggle cope influx patients leading compromised quality care economic strain Vulnerable population heightened risk developing severe complication mortality paper highlight urgent need multipronged approach encompassing surveillance case management vector control risk communication community engagement combat dengue epidemic Bangladesh Sustained political commitment adequate resources strong multisectoral collaboration imperative reduce disease burden safeguard public health face escalating threat",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40784902/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40784108",
        "title": "Community willingness to participate in a Nipah vaccine trial in Bangladesh.",
        "abstract": "Nipah virus NiV deadly zoonotic disease pandemic potential prioritized World Health Organization research vaccine development Since Bangladesh faced annual NiV outbreak repeated spillover since 2001 likely site Phase II vaccine trial study explored peoples knowledge NiV willingness participate NiV vaccine trial Bangladesh conducted mixed method study collecting qualitative quantitative data Mirpur township Dhaka NiVaffected Faridpur District December 2021 November 2022 team interviewed adult male female respondent responsible household treatment vaccination decisions team conducted 66 indepth interview 978 survey interviews Many indepth interviewee aware NiV and asked would participate NiV vaccine trial responded one three options willing unwilling would decide later concerned vaccine safety side effect making decision participation survey respondent Mirpur township Dhaka heard disease transmitted bat people 57  272478 vs 52  262500 willing participate vaccine trial 45  217478 vs 22  111500 Faridpur high number expressed willingness take investigational NiV vaccine outbreak Dhaka 75  205272 vs Faridpur 81  398491 Faridpur find association knowledge NiV willingness participate NiV vaccine trial Many respondent expressed willingness participate NiV vaccine trial especially outbreak suggesting trial may feasible Bangladesh Given concern safety side effects clear communication issue may support informed participation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40784108/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40783163",
        "title": "Epidemiology, clinical characteristics and genetic diversity of Nipah virus strains from Bangladesh: 2016 to 2023.",
        "abstract": "Nipah virus NiV cause deadly outbreak Bangladesh fatality rate 71 Two sublineages NiVBD 1 NiVBD 2 identified study aimed characterize epidemiological clinical diversity study analyzed 21 new 20162023 17 previously 20122015 reported NiV genome sequence compared sublineages using descriptive bivariate analysis Median age sequenced case 17 year IQR 930 66 male Raw date palm sap consumption main transmission pathway 92 NiVBD 2 showed broader geographic distribution including southern region sublineages differ significantly age sex transmission modes sublineages presented fever altered mental status unconsciousness Respiratory distress frequent NiVBD 2 2329 cases hospitalization longer NiVBD 1 median 3 days IQR 123 Overall mortality 84 significant difference sublineages Phylogenetic analysis demonstrated NiVBD 1 NiVBD 2 formed distinct cluster 98729925 nucleotide 99989999 amino acid identity structural nucleoprotein N matrix M protein remained conserved across sublineages study highlight genetic spatiotemporal clinical variation sublineages emphasizing continuous genomic surveillance inform future vaccine therapeutic strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40783163/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40781305",
        "title": "How did health service utilization and delivery change during the COVID-19 pandemic? Frontline healthcare workers' perceptions from the Central African Republic, the Democratic Republic of Congo, and Bangladesh.",
        "abstract": "country experienced disruption essential health service since beginning COVID19 pandemic risk prioritization COVID19 leading diversion resource health staff Disruptions particularly concerning humanitarian fragile setting due preexisting vulnerabilities investigated healthcare worker HCW perceived change health service provision whether programmatic adaptation introduced three humanitarian settings Key informant interview conducted 29 39 54 frontline HCWs Central African Republic Democratic Republic Congo Bangladesh respectively interview coded two author using deductive inductive coding Data organized framework thematic analysis conducted identify similarity discrepancy across respondent study sites Data collected March July 2021 country HCWs perception varied across service countries HCWs reported decreased consultation maternal newborn health sexual reproductive health communicable diseases communitybased activities mixed perception across country vaccinations nutrition noncommunicable diseases referrals Reasons reduced healthcare utilization included fear contracting COVID19 receiving COVID19 vaccine compliance movement restrictions financial barriers medication stockouts Factors specific humanitarian setting included insecurity population displacement presence technical partner lack medical equipment staff shortages Infection prevention control measure ie patient triage maskwearing physical distance hand washing introduced countries service adaptation included spaced consultations reduced group size extended drug prescriptions change nutrition protocols telemedicine shift COVID19 focus awareness activities first year COVID19 pandemic HCWs reported varying healthcare utilization according different service context three humanitarian settings Program adaptation address COVID19 risk introduced Although guidance existed global level contextual factor insecurity displacement preexisting capacity affected healthcare utilization health service delivery COVID19 pandemic especially DRC CAR number reported COVID19 case remained low several months",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "Democratic Republic of the Congo",
            "Bangladesh",
            "Female",
            "Health Personnel",
            "Male",
            "Adult",
            "Central African Republic",
            "SARS-CoV-2",
            "Delivery of Health Care",
            "Attitude of Health Personnel",
            "Patient Acceptance of Health Care",
            "Middle Aged",
            "Interviews as Topic",
            "Qualitative Research",
            "Pandemics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40781305/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40779535",
        "title": "The role of financial stress, food insecurity, and COVID-19-related illness concerns shaping mental health in five South Asian countries during the pandemic (2020-2022): A secondary analysis of the online COVID-19 Trends and Impact Survey (CTIS) data.",
        "abstract": "COVID19 pandemic substantially impacted mental health worldwide yet little attention given acute longterm effect mental health low middleincome country LMICs study investigates triad pandemicrelated worriesfinancial stress food insecurity COVID19related illness concernsare associated depression anxiety across five South Asian LMICs Bangladesh India Nepal Pakistan Sri Lanka Using data COVID19 Trends Impact Survey CTIS analyzed response 36 million participant collected June 27 2020 June 25 2022 employed surveyweighted logistic regression model based complete case N  1062786 adjusting demographic calendar time Due substantial change survey design May 20 2021 analysis divided two distinct periods Period 1 prechange Period 2 postchange main finding reveal three type pandemicrelated worry significantly associated increased level depression anxiety across studied countries Period 1 randomeffects metaanalysis showed financial stress highest pooled adjusted odds ratio OR depression 241 95 confidence interval CI 226 258 followed COVID19related illness concern 158 95 CI 143 175 food insecurity 152 95 CI 140 167 Period 2 pooled adjusted depression increased 274 95 CI 238 312 financial stress food insecurity showed notable rise 242 95 CI 223 262 Heterogeneity across country substantial Formula see text ranged 6033 8668 except association food insecurity depression Period 2 Countryspecific analysis confirmed results Additionally calendar time vaccination status gender education ruralurban residential status modified associations result underscore need targeted intervention address socioeconomic stressor improve mental health resilience LMICs",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40779535/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40766357",
        "title": "Typhi Mykrobe: fast and accurate lineage identification and antimicrobial resistance genotyping directly from sequence reads for the typhoid fever agent <i>Salmonella</i> Typhi.",
        "abstract": "Typhoid fever result systemic infection iSalmonella entericai serovar Typhi Typhi cause 10 million illness annually Disease control relies prevention water sanitation hygiene intervention vaccination effective antimicrobial treatment Antimicrobial resistant AMR Typhi lineage emerged become established many part world Knowledge local pathogen population informed genomic surveillance including lineage defined GenoTyphi scheme AMR determinants increasingly used inform local treatment guideline inform vaccination strategy Current tool genotyping Typhi require multiple read alignment assembly step validated analysis data generated Oxford Nanopore Technologies ONT longread sequencing devices Here introduce Typhi Mykrobe command line software tool rapid genotyping Typhi lineages AMR determinants plasmid replicons direct sequencing reads validated Typhi Mykrobe lineage genotyping comparison current standard read mappingbased approach demonstrated 998 concordance across nearly 13000 genome sequenced Illumina platforms isolates discordant calls show Typhi Mykrobe result better supported evidence raw sequence read data result generated using mappingbased approach also demonstrate 999 concordance detection AMR determinant compared current standard assemblybased approach similar result plasmid marker detection Typhi Mykrobe predicts clinical resistance categorisation SIR eight drug classes show strong agreement phenotypic categorisation generated reference laboratory minimum inhibitory concentration MIC data n1572 Illuminasequenced isolates 99 agreement within one doubling dilution show strong concordance 96 genotype 98 AMR plasmid call made ONT read made Illumina read isolates sequenced platform n 93 genomes Typhi Mykrobe take less minute per sample available httpsgithubcomtyphoidgenomicsgenotyphi Typhi Mykrobe provides rapid sensitive genotyping Typhi genome direct Illumina ONT reads although lower accuracy observed R9 ONT data demonstrated accurate assignment GenoTyphi lineage detection AMR determinant prediction corresponding AMR phenotypes identification plasmid replicons",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40766357/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40763727",
        "title": "An O-Specific Polysaccharide Shigella flexneri 3a Conjugate Vaccine is Immunogenic and Protective against Virulent Keratoconjunctival Challenge in Guinea Pigs.",
        "abstract": "Shigella infection major cause diarrhea cognitive physical stunting death young child resourcelimited settings vaccine protective shigellosis needed Immune response target Ospecific polysaccharide OSP Shigella spp protective shigellosis previously reported development evaluation conjugate vaccine targeting Shigella flexneri S flexneri 3a mice Here report evaluation vaccine Shigella conjugate vaccine S flexneri 3a OSP conjugated 52 kiloDalton recombinant fragment tetanus toxin heavy chain SCVSf3a OSPrTTHc second animal model guinea pig vaccine induced prominent OSP lipopolysaccharide rTTHcspecific Immunoglobulin IgG IgA IgM response serum vaccinated animals Shigella conjugate vaccine S flexneri 3a also induced serum bactericidal functional antibody responses vaccinated guinea pig protected virulent strain keratoconjunctival challenge standard Shigella Sereny assay result support development SCVSf3a OSPrTTHc",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40763727/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40756454",
        "title": "Global Burden of Human Metapneumovirus: Bridging Gaps in Prevention, Diagnostics and Treatment.",
        "abstract": "Human metapneumovirus hMPV respiratory virus significant impact particularly paediatric population yet remains underrecognized contributor respiratory infection globally Recent epidemic China India Europe underscore clinical burden severe case linked bronchiolitis pneumonia exacerbation chronic conditions Despite impact hMPV remains underdiagnosed due limited access molecular diagnostics routine surveillance particularly low middleincome countries absence antiviral vaccine exacerbates public health challenge Advances multiplex diagnostics vaccine development offer hope require sustained global investment Addressing gap prevention diagnostics treatment critical mitigating hMPVs growing threat ensuring equitable healthcare outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40756454/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40756412",
        "title": "Barriers and drivers to childhood vaccinations in Forcibly Displaced Myanmar Nationals (FDMN)/Rohingya refugees in Cox's Bazar, Bangladesh: a scoping review.",
        "abstract": "one million Forcibly Displaced Myanmar Nationals FDMNRohingya refugee live refugee camp Coxs Bazar experiencing recurring vaccinepreventable disease outbreak despite established vaccination programs scoping review focused evidence individual context barriers drivers intervention childhood vaccination uptake FDMNRohingya refugee Coxs Bazar Four database grey literature systematically searched Theoretical framework used organize findings 4014 record screened 21 article included literature heterogenous Barriers driver FDMNRohingya refugee receiving vaccination focused motivation relating trust belief fear 19 barrier driver 11 articles accessibility information availability 19 barrier driver 11 articles well knowledge ability eight barrier driver nine articles sociocultural genderrelated norm social support seven barrier driver eight articles health service provider facilitating vaccinations context factors availability vaccine staff frequently identified 13 barrier driver 12 articles Interventions mostly related vaccination campaign informationeducation often lacked detail formal evaluations Future research intervention childhood vaccination consider barrier driver health service providers diversity camp population explore role communityreligious leader genderrelated social norms Additionally reporting evaluation intervention strengthened httpsdoiorg1017605OSFION6D3URL httpsosfion6d3z",
        "mesh_terms": [
            "Humans",
            "Refugees",
            "Myanmar",
            "Vaccination",
            "Bangladesh",
            "Health Services Accessibility",
            "Child",
            "Male",
            "Female",
            "Health Knowledge, Attitudes, Practice"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40756412/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40754580",
        "title": "A cost-benefit analysis of using wastewater monitoring to guide typhoid vaccine campaigns.",
        "abstract": "Enteric disease leading cause mortality developing countries yet highly preventable Typhoid vaccine remain underutilized diagnostic capacity constraint impede treatment prevention Wastewater monitoring could provide accurate picture disease burden detection quantification Salmonella Typhi wastewater advanced motivate country invest improve wastewater testing methods conducted costbenefit analysis quantifying value approach could yield estimated benefit could accrue wastewater data informed early launch theoretical typhoid vaccine campaign Coxs Bazar Bangladesh empirically estimating leadtime advantage wastewater data clinical data flag case upticks simulated change case count 1 14day early campaign launch using ordinary differential equation modeling quantified benefit resulting averted case from preserved caregiver time school days wages hospitalization from saving public funds death using value statistical life calculated cumulative benefits costs ratio two varied campaign launch timing scenario fiveyear period Wastewater concentration Salmonella Typhi upticked 13 day case counts Cumulative benefit varied year launch timing 13day early launch every 100 spent wastewater monitoring could yield 295 societal benefit year 5 Cumulative benefit roughly equaled cumulative cost 5day early launch outweighed cost campaign launched even earlier wastewater data advanced reliably provide early warning new typhoid outbreaks government could reap large benefit justify spending program implementation finding could generalize highaid country that like Bangladesh experience routine enteric disease outbreak strong operational networks",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40754580/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40750539",
        "title": "Exosome: The hidden messengers in cancer detection and immunotherapy.",
        "abstract": "Cancer continues pose significant global health challenge driving need innovative approach early detection treatment management Exosomes small extracellular vesicle secreted various cell types play pivotal role intercellular communication transferring molecular cargo donor recipient cells emerged key player cancer progression therapy Exosomes contribute tumor growth mediating immune suppression drug resistance metastasis Yet distinctive property also present valuable tool cancer diagnosis Tumorderived exosomes abundant body fluids promising candidate liquid biopsies offering noninvasive biomarkers aid cancer detection prognosis realtime monitoring disease progression Beyond diagnostics exosomes forefront cancer immunotherapy particularly developing exosomebased vaccine targeted therapies capacity deliver molecular cargo directly cancer immune cell allows personalized highly effective cancer treatments review explores current understanding exosomes cancer biology underscore emerging diagnostic potential examines transformative role advancing future cancer immunotherapy strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40750539/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40744673",
        "title": "Association of women's empowerment with childhood immunisation coverage in South and Southeast Asia: meta-analysis of Demographic and Health Surveys data from 11 countries.",
        "abstract": "Child health gender inequality significant global public health issue demand immediate action particularly South Southeast Asian SSEA country challenge prevalent study examines association womens empowerment child vaccination coverage 11 SSEA low middleincome countries Using populationlevel crosssectional data Demographic Health Surveys across 11 SSEA countries developed IndividualLevel Womens Empowerment Index ILWEI based three dimension womens empowerment decisionmaking autonomy attitude towards intimate partner violence social independence threestage mixedeffect individual participant data metaanalysis employed assess association ILWEI childhood immunisation coverage India 8128 woman reported participation three four decisionmaking areas followed 6207 Bangladesh Full immunisation coverage ranged 3243 Afghanistan 6330 Bangladesh association womens empowerment vaccination coverage varied across South Southeast Asia strongest positive association observed Pakistan However mixed negative association found country India TimorLeste finding indicate several SSEA countries including Pakistan Cambodia Philippines Afghanistan higher level individual womens empowerment positively associated increased likelihood childhood immunisation coverage However country India Myanmar TimorLeste higher womens empowerment associated lower odds childhood immunisation highlighting potential contextual systemic barrier may hinder vaccination uptake underscore critical role womens empowerment enhancing childhood vaccination intake also emphasising need targeted intervention address countryspecific challenges Coordinated multifaceted strategy essential empower woman thereby support immunisation child across regions",
        "mesh_terms": [
            "Humans",
            "Female",
            "Vaccination Coverage",
            "Asia, Southeastern",
            "Empowerment",
            "Cross-Sectional Studies",
            "Health Surveys",
            "Adult",
            "Child",
            "Adolescent",
            "Middle Aged",
            "Decision Making"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40744673/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40742520",
        "title": "Genetically Modified Lactic Acid Bacteria: a Promising Mucosal Delivery Vector for Vaccines.",
        "abstract": "advent mucosal vaccine target primary entry point many pathogen revolutionized field immunology Genetically modified lactic acid bacteria gmLAB include genus Lactobacillus Bifidobacterium emerged promising vector delivering antigen mucosal surfaces grampositive nonpathogenic microorganism exhibit inherent probiotic properties survive gastrointestinal tract efficiently interact host immune system Advances genetic engineering enabled expression wide range antigen gmLAB promote systemic mucosal immunity Studies demonstrated gmLABbased mucosal vaccine elicit mucosal systemic immune responses providing protective immunity specific pathogenic infections addition gmLAB vector offer good safety profiles stability costeffective production compared traditional vaccine platforms Recent study demonstrated potential LAB vaccine preventing infection caused viral bacterial parasitic pathogen immunotherapy treating allergy cancers review highlight mechanism underlying gmLABbased mucosal vaccine delivery current advancements challenges prospect recombinant mucosal vaccines",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40742520/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40733731",
        "title": "Innate Immune Response to Powassan Virus Infection: Progress Toward Infection Control.",
        "abstract": "Powassan virus emerging tickborne flavivirus pose significant threat human health outcome Powassan virus infection shaped viral factor host immune response review aimed examine innate immune response particularly tolllike receptormediated immune response Powassan virus data specific immune response Powassan virus remain scarce Therefore focused tolllike receptor response related flavivirus infer possible mechanism host response Insights vivo vitro study critical guiding development effective therapeutic preventive strategies Currently clinically approved treatment vaccine Powassan virus highlighting urgent need development also highlight recent progress POWV vaccine development emphasis potential use tolllike receptor agonist adjuvant enhance immunogenicity improve vaccine efficacy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40733731/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40733730",
        "title": "Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines.",
        "abstract": "bBackgroundb effective vaccine Nipah virus NiV crucial due high fatality rate recurrent outbreak South Southeast Asia Vaccine development challenged lack validated accessible neutralization assays virus culture requires BSL4 facilities restricting implementation resourcelimited settings address this standardized validated pseudotyped virus neutralization assay PNA assessing NiVneutralizing antibody BSL2 laboratories bMethodsb NiVPNA validated following international regulatory standards using replicationdefective recombinant Vesicular stomatitis virus rVSV backbone dependent pseudotyped virus Assessments included sensitivity specificity dilutional linearity relative accuracy precision robustness assay calibrated using International Standard antiNiV antibody characterized reference serum ensure reliable performance bFindingsb Preliminary evaluation developed NiVPNA showed 100 sensitivity specificity across 10 serum sample 5 positive 5 negative positive correlation calibrated reference assay Rsup2sup  08461 Dilutional linearity Rsup2sup  09940 accuracy 9818 confirmed across analytical titer range 111728 IUmL assay also exhibited high precision intraassay intermediate precision geometric coefficient variation 666 1563 respectively Robustness testing demonstrated minimal variation across different pseudotyped virus lots incubation times cell counts bConclusionsb validated NiVPNA reproducible scalable assay platform quantifying NiV neutralizing antibodies offering safer alternative virus culture validation integration CEPI Centralized Laboratory Network enhance global capacity vaccine evaluation outbreak preparedness",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40733730/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40733519",
        "title": "Cellular and Humoral Immune Profiles After Hepatitis E Vaccination and Infection.",
        "abstract": "Hepatitis E virus HEV cause significant morbidity mortality globally particularly affecting vulnerable population pregnant women HEV239 Hecolinsup®sup recombinant vaccine containing immunodominant protruding E2 domain HEV capsid protein demonstrated effectiveness yet detailed human cellular immune response remain understudied study characterized humoral cellular immune response following vaccination HEV239 natural HEV infection healthy Bangladeshi woman aged 1639 years Using dual IFNγ IL4 ELISpot assays found robust predominantly Th1mediated cellular response 30 day third vaccine dose comparable response acute infection Longitudinal antibody assessment confirmed sustained antibody production primarily E2 domain genotype 1 3 persisting two year postvaccination Despite limitation related sample size assay sensitivity finding underscore immunogenic potential HEV239 support broader use HEVendemic regions",
        "mesh_terms": [
            "Humans",
            "Hepatitis E",
            "Female",
            "Hepatitis E virus",
            "Adult",
            "Adolescent",
            "Immunity, Humoral",
            "Young Adult",
            "Immunity, Cellular",
            "Vaccination",
            "Viral Hepatitis Vaccines",
            "Bangladesh",
            "Hepatitis Antibodies",
            "Antibodies, Viral",
            "Vaccines, Synthetic",
            "Capsid Proteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40733519/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40721546",
        "title": "Factors associated with common prevalent diseases in the Sonali chicken farms of the different regions of Bangladesh: a retrospective study.",
        "abstract": "study aimed determine factor associated common disease prevalence Sonali chicken farm different region Bangladesh total 243 farm randomly selected four Bangladesh district collect retrospective data study found prevalent disease Newcastle Disease 7654 Infectious Bursal Disease 5144 Avian Influenza 2963 Colibacillosis 2263 Coccidiosis 6955 Brooder Pneumonia 3498 Ascariasis 2016 secondary group education level farmer 849 visitor allowance farm 819 farm dead bird buried 913 significantly P ≤ 005 higher prevalence ND potential flocklevel protective factor ND prevalence visitor allowed farm OR  050 95 CI 028092 P  0024 dead chicken disposal buried OR  021 95 CI 008056 P  0000 Farmers used deep well 569 clean feeder drinker every 3 day 722 higher prevalence P ≤ 005 IBD risk factor IBD Sonali chicken farmer idea vaccine transportation maintain temperature OR  177 95 CI 101313 P  0048 Rangpur district 448 farm used cefalexin 511 farm brooding period farm farmer idea chick grade higher prevalence P ≤ 005 AI farm whose farmer bought chick hatchery 367 noticeably P ≤ 005 higher prevalence colibacillosis Mymensingh district 800 male farmers farm 747 largescale farm 875 farm wood shaving used litter 778 higher prevalence P ≤ 005 coccidiosis Rangpur district 492 farm farmer practicing handwashing 415 maintain routine cleaning feeder drinker 436 use antibiotic brooding period 681 higher prevalence brooder pneumonia Kishoreganj district 300 male farmer 221 farmer primary education level 307 Largescale farm 25015200 birds 251 farm using wood shaving litter material 356 farm sourcing chick hatchery 230 farm used florfenicol 308 antibiotic brooding period significant P ≤ 005 higher prevalence Ascariasis Poor biosecurity improper waste management inexperience chick quality  antibiotic used missing regular vaccination make farm likely experience disease outbreaks",
        "mesh_terms": [
            "Animals",
            "Chickens",
            "Bangladesh",
            "Retrospective Studies",
            "Poultry Diseases",
            "Prevalence",
            "Risk Factors",
            "Animal Husbandry",
            "Farmers",
            "Farms",
            "Male"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40721546/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40716798",
        "title": "Is rotavirus aetiology in young children with acute diarrhoea associated with sociodemographic and clinical factors, including rotavirus vaccination status? A secondary cross-sectional analysis of the ABCD trial.",
        "abstract": "One leading cause global child mortality continues diarrhoea rotavirus contributed 24 death among diarrhoeal deaths mostly lowincome middleincome countries Rotavirus vaccination programme contributed reduction mortality 24 19 rotavirus infection among hospitalised children burden rotaviral diarrhoea remains high especially setting undernutrition aimed determine association rotaviral diarrhoea aetiology prior vaccination socioeconomic status clinical factor child see utility clinical settings analysed secondary data multicentre clinical trial antibiotic impact child diarrhoea increased risk mortality used stored stool sample 6697 child aged 223 month old presenting health facility diarrhoea increased risk mortality determined rotavirus aetiology prevalence using quantitative PCR qPCR looked association patients rotaviral vaccination status clinical symptom sociodemographic characteristics Prevalence ratio PR calculated logbinomial regression models converge logPoisson model used Rotavirus prevalence 211 observed weak statistically nonsignificant inverse association rotavirus vaccination rotaviral diarrhoea aetiology adjusted PR 071 95 CI 049 103 five tested clinical symptoms shorter diarrhoea duration associated rotaviral aetiology PR 265 95 CI 129 545 seven tested socioeconomic characteristics maternal paternal secondary education compared formal education associated rotaviral aetiology PR 086 95 CI 074 100 PR 087 95 CI 075 100 respectively Rotaviral diarrhoea aetiology cannot accurately determined prior receipt rotavirus vaccination among child presenting facility diarrhoea increased risk mortality Short diarrhoea duration parental secondary education associated increased prevalence rotaviral aetiology however utility clinical care remains unclear",
        "mesh_terms": [
            "Humans",
            "Rotavirus Infections",
            "Infant",
            "Male",
            "Female",
            "Rotavirus Vaccines",
            "Cross-Sectional Studies",
            "Diarrhea",
            "Vaccination",
            "Prevalence",
            "Rotavirus",
            "Socioeconomic Factors",
            "Acute Disease"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40716798/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40718465",
        "title": "Cervical cancer trends, HPV vaccine utilization, and screening in low- and lower-middle-income countries: an updated review.",
        "abstract": "Cervical cancer fourth common cancer among woman worldwide 660000 new case 350000 death reported 2022 disease mainly affect woman low lowermiddleincome country LMICs 90 case occur study explored LMICs responding World Health Organizations WHO call eliminate cervical cancer looked cervical cancer rates use human papillomavirus HPV vaccines suggested strategy fight disease study analyzed rate cervical cancer death LMICs effectiveness HPV vaccination programs well screening effort working compare data across countries used agestandardized incidence rate ASIRs agestandardized mortality rate ASMRs per 100000 woman per year 2022 ASIR 254 lower income country 169 lowermiddleincome countries ASMR also higher lower income country 185 compared lowermiddleincome country 103 HPV vaccine coverage remains low many LMICs significant difference rate first final dos completed 2050 number new cervical cancer case expected rise Although aim eliminate cervical cancer achieving 90 HPV vaccination age 15 70 screening coverage 90 access treatment many challenge remain LMICs include weak healthcare systems poor infrastructure lack health education Overcoming challenge better vaccine distribution improved screening programs stronger healthcare system essential eliminate cervical cancer",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40718465/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40702012",
        "title": "Nipah virus vaccines evaluated in pigs as a 'One Health' approach to protect public health.",
        "abstract": "Nipah virus NiV cause severe neurological disease humans first NiV outbreak Malaysia involved pigtohuman transmission resulted significant economic loss local pig industry Despite risk NiV pose pigdense regions licensed vaccine exist study therefore assessed three NiV vaccine candidate pigs 1 adjuvanted soluble NiV sG protein 2 adjuvanted prefusion stabilised NiV mcsF protein 3 adenoviral vectored NiV G ChAdOx1 NiV G NiV sG induced strongest neutralising antibody response NiV mcsF induced antibody best able neutralise cellcell fusion whereas ChAdOx1 NiV G elicited CD8supsup Tcell responses Despite difference immunogenicity primeboost immunisation candidate conferred high degree protection NiV infection Followup study demonstrated longevity immune response broadly comparable immune response Bangladeshi pig field conditions study provide platform developing NiV vaccine pigs",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40702012/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40701374",
        "title": "Childhood diarrheal infections among the multi hazard disaster risk zones in Bangladesh: A household level analysis.",
        "abstract": "Bangladeshs geographic climatic condition make highly disasterprone increasing vulnerability underfive child diarrheal infections study analyzed MICS Bangladesh 2019 dataset using multivariable logistic regression model assess diarrhea prevalence low moderate high multihazard risk zones focusing floods tornadoes cyclones earthquakes Diarrhea prevalence highest highrisk zone 771  followed moderate 598  lowrisk zone 467  Socioeconomic factor male gender urban residence extreme poverty lack handwashing facility associated higher risk diarrhea highrisk zones though link weaker moderate lowrisk zones Public health official aid organization must mitigate increased diarrheal disease risk following extreme events Interventions prioritize highrisk area awareness campaigns early warning systems improved water sanitation hygiene moderate highrisk zones vaccination particularly impoverished household disasterprone regions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40701374/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40696437",
        "title": "Interplay between the gut microbiome and typhoid fever: insights from endemic countries and a controlled human infection model.",
        "abstract": "Typhoid fever systemic infection caused Salmonella enterica serovar Typhi S Typhi invasion gut lumen Transmission people occurs ingestion contaminated food water particularly setting poor water sanitation infrastructure resulting 10 million illness annually pathogen invades via gastrointestinal tract plausible gut microbiome may influence outcome S Typhi exposure evidence bacteria producing shortchain fatty acid SCFAs may create environment unfavourable invasive Salmonella data human limited investigate association gut microbiome typhoid fever analysed sample collected three allage cohort enrolled prospective surveillance study conducted across three setting typhoid fever endemic Dhaka Bangladesh Blantyre Malawi Kathmandu Nepal Cohorts consisted acute typhoid fever patient n  92 asymptomatic household contact typhoid fever patient representing individual likely exposed S Typhi develop disease n  97 asymptomatic serosurvey participant high Vi antibody titre representing individual exposed S Typhi may carriers n  69 stool microbiomes cohort characterised using shotgun metagenomics bacterial diversity composition function compared identified 4 bacterial specie significantly lower abundance typhoid fever patient compared household contact ie probably exposed two three participant population Bangladesh Malawi bacteria may represent taxon provide protection development clinical infection upon exposure S Typhi include inflammationassociated specie Prevotella copri clade Haemophilus parainfluenzae functional analysis identified 28 specific metabolic gene cluster MGCs negatively associated typhoid fever Bangladesh Malawi including seven MGCs involved SCFA metabolism putative protection provided microbiome SCFA metabolism supported data controlled human infection model conducted UK population participant develop typhoid fever following ingestion S Typhi higher abundance putative SCFAmetabolising MGC qvalue  022 study identified protective association taxonomic functional microbiota characteristic nonsusceptibility typhoid fever across multiple human populations Future research explore potential functional role SCFAs inflammationassociated bacteria resistance S Typhi enteric infections Video Abstract",
        "mesh_terms": [
            "Humans",
            "Typhoid Fever",
            "Gastrointestinal Microbiome",
            "Salmonella typhi",
            "Prospective Studies",
            "Male",
            "Female",
            "Malawi",
            "Adult",
            "Bangladesh",
            "Nepal",
            "Adolescent",
            "Child",
            "Feces",
            "Young Adult",
            "Endemic Diseases",
            "Fatty Acids, Volatile",
            "Middle Aged",
            "Child, Preschool"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40696437/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40689249",
        "title": "Epidemiological and Clinical Features of Enterotoxigenic <i>Escherichia coli</i> (ETEC) Diarrhea in an Urban Slum in Dhaka, Bangladesh.",
        "abstract": "Enterotoxigenic iEscherichia colii ETEC major cause diarrheal illness populationbased data incidence clinically significant ETEC diarrhea developing country limited provide insight ETEC epidemiology followed populationbased cohort vaccine trial analyzed data clusterrandomized controlled trial oral cholera vaccine conducted urban slum Dhaka Bangladesh study cover 90 geographical cluster average population 2988 householdscluster baseline population 268 896 Two cohort analysis conducted 1 dynamic cohort included subject vaccination inmigrants birth 4 year closed cohort included individual present baseline evaluated individual placed treatment centerbased diarrheal surveillance 2011 2015 dynamic cohort ETEC incidence 150100 000 personyears PY 95 CI 141159 seasonal peak warmer months closed cohort incidence 153100 000 PY 95 CI 140 166 highest rate seen child aged 1 year 2007 95 CI 16642402 aged 14 year 314 95 CI 252386 rate rose aged 45 year 219100 000 PY 95 CI 177267 rate severe ETEC ≤35100 000 PY person aged ≤45 year 95 CI 2744 rose 82 adult aged 45 year 95 CI 58113 ETEC diarrhea major health problem young child older adults prevention vaccination improved water sanitation hygiene target age groups",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40689249/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40687549",
        "title": "Comparative Analysis of Preferences and Willingness to Pay for COVID-19 Vaccine Among Individuals With and Without Chronic Diseases: A Discrete Choice Experiment Approach.",
        "abstract": "rapid development deployment COVID19 vaccine pivotal global battle pandemic However vaccine acceptance remains critical determinant effectiveness numerous study explored factor influencing vaccine acceptance notable dearth research regarding preference willingness pay WTP among individual chronic disease ChD heightened risk severe COVID19 outcomes study address gap investigating COVID19 vaccine preference WTP among individual without chronic diseases Employing discrete choice experiment DCE approach interviewed 843 participant assess preference COVID19 vaccine attribute origin efficacy level protection duration provider used mixed logit model analyze DCE data estimated WTP taking negative ratio preference price parameters Furthermore performed stratified analysis according household heads ChD status expected vaccine higher efficacy longer protection preferred Interestingly research show preference European American vaccine Chinese vaccines Additionally study reveals preference private facility government facility vaccination among vaccine seekers Patients ChD exhibit higher WTP without conditions demonstrating groups urgency becoming vaccinated Vaccine procurement administration decision health authority evidencebased reflect public preference regarding acceptance WTP Health authority prioritize high efficacy longlasting protection vaccine procurement ensuring neither compromised approach address top concern groupsvaccine effectiveness ChD group extended immunity NChD group study also informs policy decision regarding vaccine origin suggests incorporating private facility vaccine administration point reduce pressure government facilities",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40687549/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40678119",
        "title": "Epigallocatechin-3-gallate: a multi-target bioactive molecule derived from green tea against Oropouche virus-a computational approach to host-pathogen network modulation.",
        "abstract": "Oropouche virus OROV emerging arbovirus transmitted arthropods caused significant outbreak South Central America half million reported cases Despite public health threat approved vaccine antiviral treatment exist Oropouche fever OF study explores potential epigallocatechin3gallate EGCG bioactive polyphenol green tea antiviral agent OROV using computational approaches Due lack experimentally resolved OROV protein structures employed AlphaFold2 predict 3D model key viral proteins including RNAdependent RNA polymerase RdRp envelopment polyprotein nucleoprotein glycoprotein Gc Molecular docking revealed strong binding affinity EGCG targets particularly high interaction RNA polymerase 71 kcalmol envelopment polyprotein 87 kcalmol suggesting inhibition viral replication entry Proteinprotein interaction PPI network analysis identified critical human host gene eg FCGR3A IRF7 IFNAR1 involved immune responses Gene Ontology GO Kyoto Encyclopedia Genes Genomes KEGG pathway analysis highlighted enriched antiviral inflammatory pathways ADMET profiling indicated challenge EGCGs bioavailability including poor gastrointestinal absorption bloodbrain barrier permeability low toxicity natural origin support potential lead compound finding suggest EGCG may disrupt OROV infection multitarget mechanisms warranting experimental validation study provides foundation developing EGCGbased therapeutic OROV underscore utility computational method antiviral drug discovery",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40678119/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40672517",
        "title": "National burden and optimal vaccine policy for Japanese encephalitis virus in Bangladesh.",
        "abstract": "Bangladesh first reported Japanese encephalitis virus JEV 1977 seen regular case since however JEV vaccination program currently exists barrier use JEV vaccine limited understanding underlying burden conducted nationally representative serological community study 70 community individual age N2938 October 2015January 2016 Serum sample tested IgG antibody JEV developed spatially explicit serocatalytic model estimate underlying force infection across country used mathematical model estimate annual JE disease burden currently different vaccination strategies overall JEV seroprevalence Bangladesh 34 95CI 2841 range 028 across communities annual probability infection 0005 95CI 00030009 risk greatest near border regions estimated annually 157 clinical case 95CI 89253 31 death 95CI 1852 vaccination strategy 10 affected district 60 115 year old would require 5 million dos avert 1 case per 100000 dos five year compared 35 million dos 05 case averted nationwide campaign vaccination scenario costeffective willingnesstopay threetimes gross domestic product spatially targeted vaccine campaign would effective reducing JEV burden however would still meet standard cost effectiveness targets CDC",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40672517/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40650256",
        "title": "Potent Inhibition of Chikungunya Virus Entry by a Pyrazole-Benzene Derivative: A Computational Study Targeting the E1-E2 Glycoprotein Complex.",
        "abstract": "Chikungunya virus CHIKV continues pose significant global health challenge due absence effective antiviral treatment limited vaccine availability study employed comprehensive silico workflow incorporating highthroughput virtual screening binding freeenergy calculations ADMET absorption distribution metabolism excretion toxicity analysis 200 n molecular dynamic MD simulations identify new inhibitor targeting E1E2 glycoprotein complex crucial CHIKV entry membrane fusion Four promising candidate identified library 20000 compounds CID 136801451 showing potent binding docking score 10227 ΔGbind 5153 kcalmol top four compound exhibited favorable ADMET profiles meeting nearly criteria MD simulation confirmed stable binding strong interaction CID 136801451 E1E2 complex evidenced consistently low RMSD values finding highlight CID 136801451 promising CHIKV entry inhibitor warranting vitro vivo evaluation advance development effective antiCHIKV therapeutics",
        "mesh_terms": [
            "Chikungunya virus",
            "Antiviral Agents",
            "Virus Internalization",
            "Viral Envelope Proteins",
            "Molecular Dynamics Simulation",
            "Molecular Docking Simulation",
            "Pyrazoles",
            "Humans",
            "Protein Binding",
            "Chikungunya Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40650256/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40644485",
        "title": "Pulmonary function and comparative SARS-CoV-2 RBD-specific IgG antibody response among the COVID-19 recovered group.",
        "abstract": "Coronavirus disease 2019 COVID19 highly contagious infectious disease caused severe acute respiratory syndrome coronavirus 2 SARSCoV2 responsible million death substantial morbidity worldwide Several study report 50 individual recover acute SARSCoV2 infection experience plethora longCOVID symptom may persist weeks months even year Abnormal pulmonary function one critical manifestation longCOVID even recovering COVID19 Understanding longterm pulmonary consequence immune response among individual recovering COVID19 experienced disease severity ranging mild severe crucial comprehensive postrecovery care vaccination strategies prospective casecontrol study included 29 individual recovered COVID19 history mild severe symptom 64 controls Assessments pulmonary functional measures FVC FEV1 FEV1FVC ratio FEF MEF PEF carried following recovery COVID19 Additionally IgG antibody response examined ELISA six month multiple followup following two dos vaccination additional followup 30 day booster dose third dose Pulmonary functional abnormality prevalent recovered group previously exhibited varying symptom severity 53 mild 66 moderate 50 severe compared control group 23 Higher IgG antibody titer observed among recovered group significantly elevated titer severe moderate case following vaccination vaccination recovered group showed significantly higher titer day 14 particularly severe 1418 IUmL moderate 1390 IUmL groups compared control group 968 IUmL p  0005 Notably antibody titer negatively correlated pulmonary function test PFT parameter Forced Vital Capacity FVC Forced Expiratory Volume 1 second FEV1 group experienced significant p  0005 decrease antibody titer within 90120 day receiving two dos vaccination five six months antibody titer returned baseline levels highlighting importance vaccination additional booster dos regardless previous infection history Overall study underscore significance pulmonary function assessment postCOVID19 recovery longterm respiratory health emphasizes importance vaccination regardless infection history assess impact longCOVID respiratory health study underscore importance evaluating pulmonary function individuals whether symptomatic asymptomatic COVID19 Furthermore finding immune response analysis highlight critical role vaccination regardless infection history key strategy pandemic preparedness",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "Male",
            "Female",
            "SARS-CoV-2",
            "Immunoglobulin G",
            "Middle Aged",
            "Case-Control Studies",
            "Antibodies, Viral",
            "Prospective Studies",
            "Adult",
            "Respiratory Function Tests",
            "Aged",
            "Lung",
            "Pandemics",
            "Betacoronavirus",
            "Spike Glycoprotein, Coronavirus"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40644485/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40644440",
        "title": "Herd immunity and prevention in HPV transmission with exogenous reinfection.",
        "abstract": "Cervical cancer major global health concern primarily caused human papillomavirus HPV spread unsafe sexual contact Natural immunity often fails provide full protection permitting exogenous reinfection play key role persistence transmission HPV paper present analyzes deterministic mathematical model HPV transmission incorporating exogenous reinfection utilized VIA test result data 2019 2023 Bangladesh estimate key parameter values finding validated numerical simulation using MATLAB analytical result demonstrated strong consistency numerical outputs critical insight presence reinfectioninduced backward bifurcation indicating targeting primary infection alone insufficient eradication highlighting need address exogenous reinfection effective control propose optimal control strategy tailored resourcelimited setting like Bangladesh limited vaccine access present significant challenges communitydriven education safe sexual practice crucial continuously evolving result emphasize effective approach combine targeted prevention widespread community education precision intervention implementation essential prevent reinfection surge could prolong disease persistence undermine control efforts insight provide strong foundation refining intervention strategy offer valuable guidance controlling HPV transmission nonpharmaceutical interventions particularly resourceconstrained settings",
        "mesh_terms": [
            "Humans",
            "Papillomavirus Infections",
            "Female",
            "Immunity, Herd",
            "Uterine Cervical Neoplasms",
            "Bangladesh",
            "Reinfection",
            "Papillomavirus Vaccines",
            "Models, Theoretical",
            "Papillomaviridae"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40644440/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40641013",
        "title": "Designing of Peptide Vaccine by Investigating Monkeypox Virus Membrane Glycoprotein: An Integrated In Silico and Immunoinformatics Approach.",
        "abstract": "2022 World Health Organisation WHO announced new case developing Monkeypox Virus MPXV zoonotic orthopoxvirus viral infection mimic smallpox signs Despite ongoing infection proper medication available completely overcome infection study aim construct multiepitope vaccine targeting Monkeypox Virus MPXV membrane glycoprotein provoke robust immune responses construct potential immunodominant epitope vaccine combat MPXV target sequence sourced UAEtoIndia travel case analyzed identify potential Bcell Tcell epitope MHCI MHCII Immunodominant epitope selected fused βdefensinI PADRE increase immunogenicity vaccine modeled docked TLR3 subjected 500 n molecular dynamic simulation stability analysis Immune response bacterial expression also evaluated vaccine comprising 230 amino acids demonstrated antigenicity 06620 nonallergenicity broad population coverage Selected epitope included 3 Bcells 4 MHCI 2 MHCII ensuring potent immunodominant profile Docking TLR3 revealed binding affinity 172 kcalmol simulation confirmed stability Cloning pET28a  immune response analysis showed strong immunogenic profile including elevated IgG1 IgM antigen levels supported Codon Adaptation Index CAI 10 proposed multiepitope vaccine show promise MPXV However vivo vitro investigation essential confirm immune efficacy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40641013/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40638524",
        "title": "Clinical Epidemiology and Molecular Investigation of Protoparvovirus carnivoran1 Infection in Naturally Infected Domestic Cats in Bangladesh.",
        "abstract": "infection cat Protoparvovirus carnivoran1 global concern due likelihood infection multiple genetically similar viruses present study undertaken investigate clinicomolecular epidemiology Protoparvovirus carnivoran1 infection naturally infected domestic cat Bangladesh Rectal swab N  100 collected cat manifesting clinical sign screened presence Protoparvovirus carnivoran1 using polymerase chain reaction PCR Selected positive sample n  38 partially sequenced molecular analysis structured questionnaire developed estimate potential risk factor Protoparvovirus carnivoran1 infection clinical therapeutic outcome overall association among variables Data analysed using descriptive univariable multivariable statistical techniques overall PCR detection rate targeted Protoparvovirus carnivoran1 virus 99 99100 Young nonvaccinated animal mostly infected p  005 mortality case fatality infected cat 10 45 respectively clinical outcome vary animal receiving different therapeutic group p  019 phylogenetic analysis suggests Protoparvovirus carnivoran1 isolates share common ancestor isolates different global regions finding indicate Protoparvovirus carnivoran1 circulating Bangladesh clinicoepidemiological evolutionary outcome used guide future preventive control measure parvovirus infection locally internationally",
        "mesh_terms": [
            "Animals",
            "Bangladesh",
            "Cats",
            "Cat Diseases",
            "Parvoviridae Infections",
            "Male",
            "Female",
            "Phylogeny",
            "Polymerase Chain Reaction",
            "Risk Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40638524/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40636082",
        "title": "Comprehensive immunoinformatics guided design and in silico assessment of a multi-epitope vaccine to elicit immunity against Mayaro virus.",
        "abstract": "Mayaro virus MAYV emerging arbovirus Alphavirus genus family Togaviridae share clinical epidemiological feature arbovirus Chikungunya Dengue Zika cause Mayaro fever humans characterized febrile illness prolonged arthralgia often leading misdiagnosis Given absence licensed vaccine antiviral therapy presence competent vector endemic regions MAYV pose significant threat epidemic particularly rural South America research computational immunological method employed construct polypeptide vaccine focus structural polyprotein Mayaro virus series rigorous computational assessment used predict potent B lymphocyte epitope vaccine candidate vaccine exhibited favorable physicochemical properties stable secondary tertiary structures high solubility Molecular dynamic simulation demonstrated structural stability docking study indicated robust interaction TLR2 TLR4 receptors essential initiating immune responses Codon optimization along silico cloning demonstrated efficient expression vaccine candidate iE colii system Finally immune simulation indicated vaccine candidate could induce robust longlasting immune response online version contains supplementary material available 101007s40203025003875",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40636082/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40635997",
        "title": "<i>In-silico</i> molecular analysis and blocking of the viral G protein of Nipah virus interacting with ephrin B2 and B3 receptor by using peptide mass fingerprinting.",
        "abstract": "Nipah virus NiV zoonotic paramyxovirus closely related Hendra virus pose significant global health threat due high mortality rate zoonotic nature recurring outbreak primarily Malaysia Bangladesh India Infection NiV lead severe encephalitis carry case fatality rate ranging 40 75 lack vaccine limited understanding NiV pathogenesis underscore urgent need effective therapeutics study focus identifying viral peptide Nipah virus using peptide mass fingerprinting technique approach identified antiviral peptide acting potent inhibitors targeting viral Gproteins interaction cellular ephrinB2 B3 receptors receptor crucial viral entry host cell subsequent pathogenesis Identifying NiV viral peptide enhances understanding viruss structural functional property also open avenue developing novel therapeutic strategies blocking interaction viral Gprotein host receptors antiviral peptide offer promising prospect drug development NiV Twentyone peptide identified using peptide mass fingerprinting peptide subjected docking analysis two antiviral peptide ephrin B2 receptor monoclonal antibody demonstrating robust stability binding affinity predicted peptide contribute broader field virology elucidating key aspect NiV biology paving way development targeted antiviral therapies Future study may explore therapeutic potential peptide application combating viral infections",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40635997/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40634976",
        "title": "Integrated Immuno and bioinformatics assisted novel epitope vaccine against HIV infection: a study based on complete genome.",
        "abstract": "HIVbased complication still going high infection mortality rate requires novel strategy combat infection due unavailability proper therapeutic Therefore utilize integrated immuno bioinformatics approach study design peptide vaccine HIV infection targeting complete genome complete genome sequence analyzed potential B cell predicted Among predicted epitopes promising one selected used adjuvant linker formulate vaccine candidate vaccine modeled activity stability towards TLRs analyzed via docking dynamic 500ns vaccinegenerated immune activity expression via iiniisilicoi cloning also evaluated total 6 B cells 7 CTL 6 HTL identified immunodominant epitope used vaccine formulation epitope fused together via linkers efficiency constancy enhanced Adjuvant PADRE epitope Histag Further formulated vaccine show high population coverage stable feature based 2D 3D assessments docking investigation demonstrated strong activity vaccine towards TLR2 TLR3 binding affinity − 108 kcalmol1 − 158 kcalmol1 also disclosed remarkable constancy based 500ns simulation period vaccineassisted immune simulation expression level vector revealed robust immune response towards host based vaccination significant expression level Based integrated approach validation steps overall finding suggests formulated vaccine may strongly immunodominant property could combat infection online version contains supplementary material available 101186s12985025027640",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40634976/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40622505",
        "title": "Designing a cellular MicroRNA-based approach to silence bat-borne Nipah virus genes.",
        "abstract": "batborne Nipah virus known causing high mortality rate humans reported India Megaderma spasma Bangladesh Pteropus medius Malaysia Pteropus vampyrus different bat specie serving reservoirs virus also infects various animals often act intermediate host transmission humans Due high fatality rate associated Nipah virus outbreaks World Health Organization flagged significant public health concern prompting extensive research development antiviral therapeutic vaccines However effective vaccine therapeutic agent yet established context propose miRNAbased approach identify key human cellular miRNAs capable binding potentially cleaving degrading Nipah virus gene implicated human infections study revealed substantial number miRNA binding site across various viral genes suggesting potential mechanism gene silencing Furthermore calculated free energy value  4 kcalmol three regions downstream upstream target indicate thermodynamically favorable binding could facilitate effective miRNAmediated repression viral gene expression Additionally translational efficiency COSM value suggested swift miRNAmediated cleavage degradation viral genes Moreover analysis miRNAmRNA duplex free energy secondary structures predicted RNAFold indicated interaction human miRNAs Nipah virus gene thermodynamically stable stable duplex formation support potential efficient binding leading effective gene silencing cleavage degradation mechanisms",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40622505/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40619274",
        "title": "From Bench to Bedside in Emerging Therapies for Gynecological Malignancies: A Narrative Review.",
        "abstract": "Gynecological malignancies including cervical endometrial ovarian cancers pose significant global health challenge due increasing incidence limitation conventional treatments Current therapeutic approaches surgery chemotherapy radiation often face obstacle like multidrug resistance tumor recurrence adverse side effects response emerging therapiesincluding targeted therapy immunotherapy gene therapyare reshaping treatment paradigms Precision medicine leveraging Poly ADPribose Polymerase PARP Vascular Endothelial Growth Factor VEGF inhibitors enhances therapeutic efficacy immune checkpoint inhibitor vaccinebased therapy offer promising immunotherapeutic strategies Additionally advancement nanotechnology gene therapy including Clustered Regularly Interspaced Short Palindromic Repeats CRISPR based approach nanoparticlemediated drug delivery provide novel treatment modalities Despite innovations translational challenge persist necessitating research clinical application personalized treatment strategies review highlight latest advancement emerging therapy gynecological malignancies emphasizing potential improve patient outcome address existing treatment limitations",
        "mesh_terms": [
            "Humans",
            "Female",
            "Genital Neoplasms, Female",
            "Genetic Therapy",
            "Immunotherapy",
            "Precision Medicine"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40619274/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40601639",
        "title": "Development of a potential vaccine against Capripox virus implementing reverse vaccinology and pan-genomic immunoinformatics.",
        "abstract": "CPXV responsible animal disease affecting cattle Lumpy Skin Disease sheep Sheeppox goat Goatpox outbreaks disease huge socioeconomic effects Now vaccination effective sheeppox goatpox lumpy skin disease available work used immunoinformatic methodology discover possible target vaccination CPXV 122 CPXV protein obtained Vipr database several investigation proteins virulence antigenicity toxicity solubility IFNg activity carried out Three outer membrane extracellular protein selected predict Bcell Tcell epitope based certain distinctive features epitope exhibit conservation across three species namely Sheeppox virus SPPV Goatpox virus GTPV Lumpy skin disease virus LSDV CPXV provide comprehensive immunity diverse virus strain worldwide Nine MHCI MHCII Bcell epitope selected generate multiepitope vaccine constructions construct linked using AAY GPGPG KK linkers 50S ribosomal protein L7L12 adjuvant enhance immunogenicity vaccines Molecular modeling structural validation enabled production vaccine construct highquality 3D structures CPXV Protein A35 Protein Resolve A22 Scaffold Protein selected analysis varied immunological physiochemical property Number Amino Acids Molecular Weight Daltons Theoretical pI Aliphatic index Grand average hydropathicity GRAVY Instability index GC content CAI value docking scores bacterial expression system showed notable gene expression CPXVV5 vaccine shown computational cloning analysis Molecular dynamic MD simulation revealed structural stability longterm epitope visibility implying strong immune response delivery result suggest developed vaccine might quite safe effective practical settings offer solid foundation experimental verification",
        "mesh_terms": [
            "Capripoxvirus",
            "Animals",
            "Viral Vaccines",
            "Epitopes, T-Lymphocyte",
            "Epitopes, B-Lymphocyte",
            "Vaccinology",
            "Computational Biology",
            "Poxviridae Infections",
            "Vaccine Development",
            "Sheep",
            "Goats",
            "Viral Proteins",
            "Immunoinformatics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40601639/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40600140",
        "title": "Benchmarking pangenome dynamics and horizontal gene transfer in <i>Mycobacterium marinum</i> evolution.",
        "abstract": "Horizontal gene transfer HGT key driver microbial evolution promoting genetic diversity contributing emergence antibiotic resistance study explores pangenome dynamic HGT iMycobacterium marinumi iM marinumi close relative iMycobacterium tuberculosisi Multiple pangenome datasets analyzed quantify gene gain loss pangenome openness utilizing Panstripe Generalized Linear Model GLM framework assess gene presenceabsence across strains Additionally comparative benchmarking analysis gene ontology GO annotation conducted using eggNOG InterProScan evaluate functional annotation accuracy finding demonstrated significant difference gene gain loss rates suggesting variation annotation accuracy presence mobile genetic element MGE Single nucleotide polymorphism SNPs also identified highlighting genetic variability may impact strainspecific trait pathogenicity antibiotic resistance Pangenome iM marinumi characterized highly open substantial variability gene content reflecting ongoing genetic exchange adaptability Functional annotation benchmarking demonstrated eggNOG InterProScan provided complementary insights tool excelling distinct strength gene function identification Overall finding highlight complex interplay HGT pangenome evolution antibiotic resistance iM marinumi analytical framework presented provides robust approach future study aiming inform therapeutic intervention vaccine development",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40600140/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40599414",
        "title": "Mental Health Consequences of COVID-19 Vaccine Side Effects: Findings From a Cross-Sectional Analysis.",
        "abstract": "COVID19 pandemic intensified preexisting mental health issue Bangladesh yet study specifically examined factor related COVID19 vaccination influence mental health within context study aimed examine relationship mental health symptoms including depression anxiety stress COVID19 vaccination status related factor among adult Bangladeshi population crosssectional study convenience sampling technique employed gather data sample size response rate 1085 9368 mean age participant 3430 SD 1279 553 female Descriptive inferential statistic carried out reliability instruments measured Cronbachs alpha was depression 078 anxiety 082 stress 083 overall DASS 092 average number COVID19 vaccine dos taken 233 additional dose COVID19 vaccine significantly reduces stress score 061 Additionally prevaccination concern side effect significantly increase anxiety score 063 Furthermore experiencing pressure get vaccinated associated significant increase depression score 078 Moreover experiencing negative outcome vaccine significantly decrease score across three mental health metrics depression 091 anxiety 087 stress 135 study reveals broad psychological consequence COVID19 vaccination Bangladesh underscore importance effective communication supportive strategies alongside targeted psychological intervention vaccination sites",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40599414/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40598764",
        "title": "Attitudes and acceptance of mRNA-based vaccine for neglected tropical diseases: A multi-country study in Asia.",
        "abstract": "study seek investigate willingness receive vaccination NTDs using mRNAbased vaccine various Asian countries including China June December 2023 anonymous crosssectional survey carried five countries survey assessed knowledge attitude regarding mRNA vaccine potential impact vaccination acceptance majority indicated somewhat willing 449 193 expressed extreme willingness High knowledge score adjusted odds ratio aOR  261 95 confidence interval CI 231296 associated higher willingness receive mRNAbased NTD vaccines Participants Bangladesh recorded highest proportion expressed willingness 514 followed China 159 Vietnam 154 Malaysia 148 Pakistan 110 India 113 recorded lowest proportion willingness Understanding mechanism mRNA vaccine awareness difference mRNA vaccine conventional one knowledge item significantly predict acceptance Concerns regarding potential unknown side effect associated mRNAbased approaches perception traditional vaccine development method safer negatively correlate willingness Conversely belief advantage mRNAbased approaches rapid development heightened potency reduced cost positively correlate willingness High overall knowledge attitude score associated higher willingness receive vaccines younger age group female demonstrated greater vaccination acceptance Overall study highlight opportunity challenge promoting uptake mRNAbased vaccine NTDs Asia countries study provides insight enhancing knowledge fostering positive attitude toward mRNAbased vaccines",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "Adult",
            "Cross-Sectional Studies",
            "Health Knowledge, Attitudes, Practice",
            "Middle Aged",
            "Young Adult",
            "Neglected Diseases",
            "Patient Acceptance of Health Care",
            "Asia",
            "Vaccination",
            "Surveys and Questionnaires",
            "Adolescent",
            "mRNA Vaccines",
            "Vaccines, Synthetic",
            "RNA, Messenger"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40598764/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40598372",
        "title": "Effects of serial passaging of field isolates of Bangladeshi PPR virus in Vero cells on the fusion protein.",
        "abstract": "Fusion F protein crucial facilitating viral entry host cell contributes virulence Morbilliviruses Serial passaging Peste Des Petits Ruminants virus PPRV nonnative host lead mutation potentially reduce pathogenicity Hence study aimed investigate effect serial passaging Bangladeshi strain PPR virus Vero cell Fusion protein pathogenicity MATERIALS METHODS PPR virus initially isolated natural PPR outbreaks confirmed reverse transcriptase polymerase chain reaction RT‒PCR passaged 9th passage Vero cells sequenced preserved previous study 9th passage virus repository utilized viral inoculant passaging Vero cells 60th passage completed presence PPR viral RNA confirmed tissue culture fluid TCF RT‒PCR different passage numbers TCF 60th passage sequenced used immunogenicity study via live animal experiments subsequent immunity measured via cELISA Comparative analysis sequence 9th 60th passages along sequences revealed substitution 14 nucleotide nts 4 amino acid aa within leucine zipper structure fusion protein Notably live animal experiment demonstrated occurrence protective immunity study suggests amino acid substitution genetic divergence may positively affect viral virulence highlighting importance development potent vaccine",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40598372/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40592849",
        "title": "Personalized azithromycin treatment rules for children with watery diarrhea using machine learning.",
        "abstract": "use machine learning identify innovative strategy target azithromycin child watery diarrhea likely benefit Using data randomized trial azithromycin watery diarrhea NCT03130114 develop personalized treatment rule given set diagnostic child clinical characteristics employing robust ensemble machine learningbased procedure procedure estimate childlevel expected benefit given set covariates combining prediction library statistical models rule estimate proportion treated rule average benefit treatment Among 6692 children treatment comprehensive rule recommended average one third children risk diarrhea day 3 101 lower 95 CI 54 149 azithromycin compared placebo among child recommended treatment NNT 10 day 90 rehospitalization death risk 24 lower 95 CI 06 41 NNT 42 pathogen diagnostics strong determinant azithromycin effect diarrhea duration host characteristic may better predict benefit rehospitalization death suggests targeting antibiotic treatment severe outcome among child watery diarrhea may possible without access pathogen diagnostics",
        "mesh_terms": [
            "Humans",
            "Azithromycin",
            "Machine Learning",
            "Diarrhea",
            "Anti-Bacterial Agents",
            "Child, Preschool",
            "Female",
            "Male",
            "Infant",
            "Child",
            "Precision Medicine",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40592849/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40585639",
        "title": "Comparative Analysis of Anti-receptor Binding Domain (RBD) IgG Responses to Homologous and Heterologous SARS-CoV-2 Vaccine Regimens: A Study From Bangladesh.",
        "abstract": "COVID19 pandemic necessitated robust vaccination strategies including booster dos sustain immunity SARSCoV2 comparative immunogenicity homologous same vaccine type versus heterologous different vaccine types booster regimen remains understudied particularly diverse settings study assesses antireceptor binding domain RBD IgG antibody response regimen Bangladesh prospective quasiexperimental study conducted Bangabandhu Sheikh Mujib Medical University Dhaka Bangladesh March 2022 February 2023 Seventythree participants selected via convenience sampling grouped homologous n40 heterologous n33 vaccine regimen based primary booster vaccine types AntiRBD IgG level measured prebooster three week postbooster using SARSCoV2 IgG II Quant Reagent Kit Abbott Ireland Demographic clinical factor age sex BMI diabetes blood pressure evaluated MannWhitney U KruskalWallis test used p≤005 indicating significance Participants mean age 3551 years 795 male showed higher prebooster median 449965 vs 18637 AUmL p0001 postbooster median 1383515 vs 104233 AUmL p0014 antiRBD IgG level homologous group compared heterologous group However heterologous group exhibited greater fold increase median 46 vs 365 p0024 antiRBD IgG levels higher proportion participant homologous regimen achieved high postbooster IgG level 20000 AUmL p0016 Diabetes significantly reduced antibody response heterologous group p0006 Hypertensive participant significantly reduced antibody response p0005 p0001 booster heterologous group p0033 booster homologous group Age sex BMI significant effect results Homologous regimen yield higher antiRBD IgG levels heterologous regimen produce greater fold increase antiRBD IgG levels indicating robust recall Diabetes hypertension impair responses particularly heterologous regimens finding support need tailored vaccination strategy enhance immune protection",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40585639/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40585162",
        "title": "Evaluating the accuracy of <i>Salmonella</i> Typhi Hemolysin E and lipopolysaccharide IgA to discriminate enteric fever from other febrile illnesses in South Asia.",
        "abstract": "Existing method identify patient infected Salmonella enterica Typhi S Typhi Paratyphi inadequately accurate affordable efficient evaluated discriminatory power antibody S Typhi hemolysin E HlyE lipopolysaccharide LPS Bangladesh Nepal Pakistan Plasma concentration antiHlyE LPS IgA measured blood cultureconfirmed enteric fever case febrile control laboratoryconfirmed alternative etiology Receiver operating characteristic analysis showed combining antiLPS HlyE IgA distinguished enteric fever case febrile illness area curve AUC 093 AntiLPS IgA alone performed nearly well AUC 092 child 5 combination outperformed individual biomarkers AUC 096 vs 094 HlyE 093 LPS accurate Bangladesh Pakistan compared Nepal finding support antiHlyE LPS IgA ELISA accurate method identify enteric fever endemic settings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40585162/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40583904",
        "title": "A robust comprehensive immunoinformatics approach for designing a potential multi-epitope based vaccine against a reiterated monkeypox virus.",
        "abstract": "Mpox viral disease caused monkeypox virus MPXV public health emergency international concern since 2024 absence mpoxspecific treatment vaccine along emergence new variant like Clade Ib underscore urgent need targeted vaccine development address challenge study employed reverse vaccinology immunoinformatics approach design multiepitope vaccine MPXV vaccine construct includes four Linear B lymphocyte LBL nine Cytotoxic lymphocyte CTL seven Helper lymphocyte HTL epitopes LBL epitope selected six membrane glycoprotein virus Tcell epitope selected experimentally validated conserved epitope similar orthopoxviruses epitope combined appropriate linkers adjuvant enhance structural flexibility immunogenicity potency engineered vaccine underwent rigorous evaluation considering physicochemical properties structural integrity population coverage immune system response simulation 3D structure vaccine predicted optimized docking analysis revealed robust interaction human Tolllike receptor 2 4 TLR2 TLR4 supported highly negative HADDOCK score low RMSD values stability vaccine construct stable interaction TLR2 TLR4 confirmed molecular dynamic MD simulation Additionally immune simulation result showed vaccination significantly increased IgM level primary response IgG subtypes well combined IgM IgG level nearly doubled secondary tertiary responses iIn silicoi expression iEscherichia colii iE colii confirmed potential production Overall study present highly immunogenic promising vaccine candidate MPXV demand experimental validation clinical application",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40583904/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40580988",
        "title": "Protection from killed whole-cell cholera vaccines: a systematic review and meta-analysis.",
        "abstract": "Killed wholecell oral cholera vaccine kOCVs standard prevention control measure choleraendemic area outbreak humanitarian emergencies New evidence emerged way vaccine used changed aimed provide updated synthesis evidence protection conferred kOCV systematic review metaanalysis used search procedure previous systematic review identify randomised clinical trial RCTs observational study reported estimate protection conferred kOCVs medically attended confirmed cholera Eligible study English French Spanish Chinese published March 8 2024 including identified previous review included Data efficacy effectiveness extracted number doses duration followup age group Efficacy effectiveness estimate summarised separately using randomeffect model estimate protection time since vaccination metaregression model used estimate protection dose function time since vaccination updated study registered along original review PROSPERO CRD42016048232 identified 8205 record published online March 8 2024 including 6224 article previous review 1981 article new search after Jan 1 2016 these 53 eligible fulltext review Five RCTs ten observational study 23 publication included Average twodose efficacy 12 month vaccination 55 95 CI 4662 declining 44 2559 48 month vaccination Average twodose effectiveness 69 5878 12 month vaccination declining 47 970 48 month vaccination one RCT assessed onedose efficacy found sustained protection 24 month 57 4269 among 5 year older significant protection younger children Average onedose effectiveness 12 month vaccination 60 5168 24 month 47 3458 Using age groupspecific metaanalysis found average twodose efficacy child younger 5 year half older individuals Two dos kOCV provide protection medically attended cholera least 4 year vaccination One dose kOCV provides protection least 2 year vaccination wane faster two doses Children younger 5 year less protected kOCVs aged 5 year older regardless number dos received Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Humans",
            "Cholera Vaccines",
            "Cholera",
            "Vaccines, Inactivated",
            "Child"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40580988/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40580979",
        "title": "Killed whole-cell cholera vaccines: is the evidence sufficient for their widespread use?",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40580979/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40580038",
        "title": "Evaluating the effectiveness of COVID-19 vaccines during a period of Omicron variant predominance among Bangladeshi population: A test-negative design measurement.",
        "abstract": "study conducted estimate protective effectiveness PE complete primary booster dose regimen COVID19 vaccine deployed Bangladesh study conducted four hospital Dhaka December 30 2021 August 31 2022 following testnegative design Patients aged ≥18 year attended COVIDlike symptom enrolled tested RTPCR Testnegative control matched confirmed case 11 ratio considering site date age groups Conditional logistic regression used estimate PE considering association receipt complete primary without booster regimen development COVID19 disease symptoms Whole genome sequencing WGS carried confirm variants RTPCR positive 847 case matched 847 controls WGS strain revealed 6 Delta variant 94 Omicron variant PE conferred receipt complete primary regimen without booster dose vaccine revealed significant protection 15 95 CI 11 36 ipi  23 COVID19 disease severe disease 14 95CI 23 39 ipi  42 However protective association receipt complete primary regimen without booster dose one mRNA vaccine PfizerBioNTech COVID19 disease 88 95 CI 26 98 ipi  023 first 90 days analysis suggested little vaccine effectiveness Omicron surge possible exception one mRNAvaccine 90 day dosing",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "COVID-19",
            "SARS-CoV-2",
            "COVID-19 Vaccines",
            "Male",
            "Female",
            "Adult",
            "Vaccine Efficacy",
            "Middle Aged",
            "Immunization, Secondary",
            "Young Adult",
            "Adolescent",
            "Whole Genome Sequencing",
            "Aged",
            "Case-Control Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40580038/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40568491",
        "title": "Genomic features and pathogenic potential of <i>Streptococcus agalactiae</i> isolated from bovine clinical mastitis.",
        "abstract": "goal study describe genome iStreptococcus agalactiaei found clinical mastitis cattle Bangladesh work show strong bacteria important public health Whole genome sequencing WGS performed using Illumina MiSeq platform followed comprehensive analysis various bioinformatic tool identify key genomic features WGS revealed isolates closely related belonging sequence type ST4 rare type previously identified human animal hosts isolates possess 44 virulencerelated gene linked adherence capsule biogenesis enzyme production immunoreactive antigens protease cytolysin production also carry two pilus island PIs PI1 PI2b often associated invasive diseases PI2b protein key target vaccine development Group B Streptococcus GBS isolates belong serotype Ia carry gbs20182 variant indicating adaptability wide range hosts including human animals virulence factor critical understanding iS agalactiaeis pathogenicity developing vaccine infections Additionally isolates harbor antimicrobial resistance gene conferring resistance glycopeptides ivanTi ivanYi macrolides imreAi peptide imprFi penicillin iβilactams ipbpi aminoglycosides Source tracking via BacWGSTdb website identified isolates closely related human pathogens indicating zoonotic potential result suggest iS agalactiaei could zoonotic pathogen highlight need ongoing genomic surveillance fully understand cause disease come effective way control it",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40568491/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40563126",
        "title": "Outbreak of Ceftriaxone-Resistant Salmonella enterica Serovar Typhi, Bangladesh, 2024.",
        "abstract": "report outbreak ceftriaxoneresistant Salmonella enterica serovar Typhi Bangladesh 47 case identified AprilSeptember 2024 Isolates belonged genotype 4312 harbored blasubCTXM15sub gene pCROB1 plasmid genotypeplasmid lineage represents recent introduction calling strengthened surveillance antimicrobial stewardship vaccination strategies",
        "mesh_terms": [
            "Bangladesh",
            "Humans",
            "Salmonella typhi",
            "Ceftriaxone",
            "Typhoid Fever",
            "Disease Outbreaks",
            "Anti-Bacterial Agents",
            "Microbial Sensitivity Tests",
            "Drug Resistance, Bacterial",
            "Male",
            "Female",
            "Adult",
            "Child, Preschool",
            "Child",
            "Adolescent",
            "Middle Aged",
            "Young Adult",
            "Genotype"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40563126/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40561131",
        "title": "Use of minimally invasive tissue sampling to determine the contribution of diarrheal diseases to under-five mortality and associated co-morbidities and co-infections in children with fatal diarrheal diseases in Africa and Bangladesh.",
        "abstract": "Achieving Sustainable Development Goal reducing child mortality 25 death per 1000 live birth 2030 requires strategy prevent diarrheal diseaserelated morbidity mortality Accurate etiological diagnosis essential study used postmortem diagnostics investigate contribution diarrhea under5 mortality examine comorbidities coinfections Africa South Asia Child Health Mortality Prevention Surveillance CHAMPS generates data child death minimally invasive tissue sampling clinical record review verbal autopsies Multidisciplinary panel assign causes death using International Classification Diseases analysis included death among child aged 159 month enrolled 18 December 201631 December 2023 across six African site Ethiopia Mali Kenya Sierra Leone Mozambique South Africa Bangladesh 1517 death assessed diarrhea causal pathway 240 158 proportion diarrhearelated death highest Ethiopia 410 3483 followed Bangladesh 300 310 Mozambique 217 56258 Mali 175 18103 Kenya 139 51366 Sierra Leone 128 46358 South Africa 94 32339 Diarrhea underlying cause 442 106240 case immediateantecedent cause 583 140240 death involving multiple role causal chain diarrhea underlying cause sepsis 330 lower respiratory infection 255 common downstream conditions antecedentimmediate cause leading underlying cause malnutrition 643 HIV 136 pathogen identified 496 119240 diarrhearelated deaths among these diarrhea underlying cause 429 Among 121 pathogenattributed deaths frequent EAEC 347 typical EPEC 157 ShigellaEIEC 140 STETEC 124 rotavirus 264 adenovirus non4041 190 4041 50 pathogen frequently identified coinfections Diarrheal disease accounted substantial share child death across CHAMPS sites Reducing mortality require preventing diarrhea addressing key contributor malnutrition HIV",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40561131/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40555405",
        "title": "Evaluation of Interventions to Improve Vaccination Coverage Among Children Aged 12-23 Months in Urban Slum Areas of Bangladesh Using the WHO Interactive Evidence to Decision (iEtD) Framework: A Stakeholder Perspective.",
        "abstract": "Childhood vaccination costeffective public health intervention however coverage slumlike area remains significant challenge unique socioeconomic disparity logistical barriers aimed evaluate intervention literature improving vaccination coverage among child aged 1223 month slum area using iEtD framework TOPSISEntropy method decisionmaking Bangladesh identify stakeholder rank felt need intervention across study slums crosssectional study conducted six slum two city corporation area Dhaka Bangladesh involving 67 demandside 35 supplyside stakeholders Rating score ranged 0 1 indicating priority interventions study highlight demandside stakeholder favour incentive interventions whereas supplyside stakeholder support multicomponent strategies stakeholders educational intervention ranked highest score 0745 followed multicomponent intervention score 0666 incentive score 0651 reminderrecall scoring score 0305 Educational intervention identified shared priority common ground addressing felt need demand supplyside stakeholders finding support tailored contextspecific approach enhance vaccination coverage child health vulnerable communities",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40555405/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40532465",
        "title": "Prevalence of hepatitis B virus infection among pregnant women and cord blood hepatitis B surface antigen positive newborns in sub-Saharan Africa and South Asia.",
        "abstract": "Newborns infected Hepatitis B Virus HBV risk chronic liver disease hepatocellular carcinoma study investigated prevalence HBV infection among pregnant woman cord blood Hepatitis B surface antigen HBsAg positivity newborn Bangladesh Bhutan India Ethiopia Mozambique Kenya Nigeria Mali South Africa Randomly selected paired maternal cord blood sample n  101 site taken delivery tested HBsAg Hepatitis B extractable antigen HBeAg woman using chemiluminescent microparticle immunoassay Similarly cord blood sample newborn assessed HBsAg reactivity HBV DNA quantified using Xpert® HBV viral load assay followed genotyping overall prevalence maternal HBsAg positivity 55  95 CI 04 71  n  50909 HBsAg positivity higher African country 73  95 CI 54 96  n  44606 compared South Asian country 20  95 CI 08 43  n  6303 p  0002 Relative South Africa higher odds HBsAg seropositivity woman Mozambique aOR 77 95 CI 16 378  Mali aOR 57 95 CI 11 297  rate HBsAg positivity cord blood baby born HBsAg positive woman 280  95 CI 171 423  n  1450 including 318  95 CI 195474  n  1444 African countries cord blood HBsAg positivity observed South Asia Genotypic analysis revealed HBV genotype 417  E 583  predominant high rate cord blood positivity 280  HBsAg underscore urgency enhancing HBV prevention strategy meet World Health Organizations target 90  reduction new HBV infection 2030",
        "mesh_terms": [
            "Humans",
            "Female",
            "Hepatitis B Surface Antigens",
            "Pregnancy",
            "Fetal Blood",
            "Prevalence",
            "Infant, Newborn",
            "Hepatitis B",
            "Adult",
            "Hepatitis B virus",
            "Pregnancy Complications, Infectious",
            "Young Adult",
            "DNA, Viral",
            "Africa South of the Sahara",
            "Asia",
            "Genotype",
            "Viral Load",
            "Infectious Disease Transmission, Vertical",
            "Adolescent",
            "Hepatitis B e Antigens",
            "Asia, Southern"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40532465/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40526624",
        "title": "Determinants of incomplete immunization and factors for missed opportunities in urban Dhaka: A cross-sectional study.",
        "abstract": "vaccination immunization schedule need two dos elicit protective immune response Therefore completion dos crucial achieving best possible immunity objective study investigate factor influencing missed opportunity polio vaccination child age 13 year urban Dhaka 2018 according immunization card record history parentsguardians sorted13yearold child area Dhaka South City Corporation fully immunized Immunization record obtained Expanded Program Immunization EPI card maternal recall Reasons nonvaccination documented total 501 child tracked determine cause incomplete polio doses Determinants incomplete immunization factor missed opportunity assessed using bivariate multivariable logistic regression model household child received recommended vaccine considerably lower monthly income 18000 BDT p  0001 complete partial vaccination groups average family size five people average child age 28 months Education level household head adjustment AOR odds event occurring decrease 25 primary education 95 CI 066 085 pvalue  0001 Occupation household head rickshawvancart puller AOR odds increase even more event 315 time likely occupation 95 CI 195 508 statistical significance pvalue  005 Again daily wager AOR 216 time higher daily wager 95 CI 135 345 statistical significance pvalue 0001 study identifies sociodemographic factor influence incomplete childhood immunization urban area Dhaka order improve coverage identified factor need mitigated policymakers focus enhancing community engagement combating misinformation increasing accessibility vaccination services",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Female",
            "Child, Preschool",
            "Cross-Sectional Studies",
            "Male",
            "Infant",
            "Vaccination",
            "Urban Population",
            "Immunization Schedule",
            "Poliomyelitis",
            "Immunization",
            "Immunization Programs"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40526624/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40505670",
        "title": "Safety and immunogenicity of a reduced-dose inactivated poliovirus vaccine versus a full-dose inactivated poliovirus vaccine in infants in Bangladesh: a double-blind, non-inferiority, randomised, controlled, phase 3 trial.",
        "abstract": "Replacing oral polio vaccine inactivated polio vaccine IPVs necessary stop potential transmission vaccinederived polio viruses aimed compare safety immunogenicity dosesparing IPV dsIPV fulldose IPV infant Bangladesh doubleblind randomised controlled phase 3 study done two field site Bangladesh Kamlapur Matlab Eligible participant healthy infant aged 68 weeks parent intended reside area study period Participants randomly assigned 1111 receive either dsIPV one three lot lot A B C Serum Institute India Pune India IPV Serum Institute India Three intramuscular dos 0·5 mL administered age 6 10 14 week addition standard vaccines study staff involved safety evaluation study procedures parent participants laboratory personnel masked treatment allocations primary endpoint seroconversion poliovirus type 1 2 3 28 day third dose assessed perprotocol full analysis populations Solicited adverse event collected 4 day vaccine dose unsolicited adverse event serious adverse event collected 28 day third dose study registered ClinicalTrialsgov NCT05163561 complete Jan 9 2022 April 29 2023 1072 eligible participant randomly assigned receive dsIPV n801 IPV n267 1052 completed study 755 96 95 CI 94 97 786 participant dsIPV group versus 256 97 94 98 265 participant IPV group seroconversion poliovirus type 1 difference 0·55 95 CI 3·05 1·95 744 95 93 96 786 participant dsIPV group versus 261 98 96 100 265 participant IPV group seroconversion poliovirus type 2 difference 3·83 6·48 1·19 765 97 96 98 786 participant dsIPV group versus 260 98 96 99 265 participant IPV group seroconversion poliovirus type 3 difference 0·78 2·73 1·16 Solicited event observed 446 56 801 participant dsIPV group 143 54 267 participant IPV group Unsolicited event observed 746 93 801 participant dsIPV group 250 94 267 participant IPV group Serious adverse event observed 23 3 801 participant dsIPV group five 2 267 participant IPV group common serious adverse event pneumonia n10 dsIPV group n3 IPV group bronchiolitis n3 dsIPV group n1 IPV group diarrhoea n3 dsIPV group n1 IPV group None unsolicited event serious adverse event causally related study vaccines Delivery three intramuscular dos novel dsIPV vaccine safe immunologically noninferior delivery three intramuscular dos IPV dose sparing formulation might therefore become attractive option national immunisation programme due lower expected vaccine costs Serum Institute India",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40505670/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40496144",
        "title": "Addressing influenza in Bangladesh: closing evidence and policy gaps with strategic interventions.",
        "abstract": "Since establishment National Influenza Surveillance Program 2007 Bangladesh significantly progressed monitoring influenza national international collaboration However collaboration translated actionable control policies coupled low vaccination coverage impose substantial health economic burden Bangladesh Critical gap remain understanding influenza burden among highrisk population barrier influencing vaccine uptake gap hinder development evidencebased strategy prevention control consequently leaving country vulnerable potentially catastrophic influenza epidemic challenge require multifaceted approach including continuous local data collection disease burden vaccine barriers vaccine costeffectiveness analyses design contextspecific interventions Leveraging existing infrastructure offer opportunity develop tailored strategy highrisk populations robust national influenza policy imperative mitigate burden reduce future pandemic threats",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40496144/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40493576",
        "title": "Awareness about cervical cancer and its socio-economic determinants among adults in Bangladesh: Results from a nationwide cross-sectional study.",
        "abstract": "Cervical cancer major global health issue second leading cancer among woman Bangladesh caused primarily Human papillomavirus HPV Despite effective vaccination screening methods awareness access preventive method limited developing regions nationwide study aim explore socioeconomic cultural factor affecting cervical cancer awareness Bangladesh generate evidencebased recommendation tailoring suitable health promotion strategy country crosssectional study conducted Bangladesh evaluate cervical cancer awareness among adult aged 18 year above semistructured questionnaire designed research keeping mind local sociocultural contexts Facetoface interview conducted getting participants consent making sure understood questions checking data quality consistency response 2151 participant finally retained collected data analyzed using STATA Version 17 statistical software majority 8015 participant aware cervical cancer healthcare worker primary source information Higher awareness rate noted among married individual 8088 urban dweller 8324 education average 1196 ± 436 years individual higher income 8817 belonging nuclear family 8286 Healthcare professional significantly greater awareness 9891 compared occupations Participants undergoing regular health checkup informed association statistically significant 8703 p  0001 Univariate multiple logistic regression model revealed additional year education increased probability aware 1620 Men significantly lower odds aware compared woman Adjusted Odds Ratio AOR  041 β  0895 95 CI 023 070 p  0001 multiple logistic regression analysis Similarly respondent cohabitating spouse less aware living partner AOR  047 β  0750 95 CI 028 081 p  0006 Income level conversely influenced awareness level participant highest income group earning 3500150000 BDT 47 lower odds AOR  053 β  0629 95 CI 036 080 p  0002 awareness compared lowest income group earning ≤20000 BDT Despite widespread awareness cervical cancer among Bangladeshi adults remains notable gap particularly among certain demographics Since study identified healthcare workers social media mass medium major source information targeted educational campaign medium channel outreach activity healthcare worker might effectively enhance nationwide awareness cervical cancer",
        "mesh_terms": [
            "Humans",
            "Female",
            "Uterine Cervical Neoplasms",
            "Bangladesh",
            "Adult",
            "Cross-Sectional Studies",
            "Health Knowledge, Attitudes, Practice",
            "Middle Aged",
            "Socioeconomic Factors",
            "Young Adult",
            "Surveys and Questionnaires",
            "Adolescent"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40493576/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40489552",
        "title": "Demographic, temporal, and spatial analysis of human animal bite cases in Mymensingh District, Bangladesh.",
        "abstract": "study aimed analyze demographic temporal spatial characteristic animal bite AB case human across 12 Upazilas within Mymensingh district Bangladesh Retrospective hospitalbased data individual AB case 2022 2023 collected SK Hospital dataset included information victim demographics bite details vaccination information Rabies Immune Globulin RIG administration Additionally monthly case count 2016 2024 sourced analyzed identify trends Descriptive statistic time series analysis using seasonal decomposition technique conducted Risk map animal bite 2022 2023 generated using standardized incidence ratio SIR approach almost twofold increase proportion category 3 bite receiving RIG 36 2022 65 2023 noted 97 2022 169 2023 bite victim received PEP day exposure whereas 765 2022 846 2023 received PEP within 24 hours Moreover significant seasonal pattern annual increasing trend AB case observed Males child 14 year old higher risk bitten Dogs 482 2022 cat 526 2023 identified primary animal responsible bites Notably leg body part frequently bitten bite risk map identified four high risk Upazilas Despite improvement PEP coverage achieved within 24 hours critical gap remains sameday PEP coverage years study result also suggest potential improvement healthcare practice treatment protocols need veterinary surveillance system Increasing AB case highlight need enhance surveillance control measures Targeted awareness campaign tailored highrisk group male child 14 year age along preventive program focused dog imperative Coordinated One Health effort among healthcare professionals veterinarians policymakers community stakeholder crucial effectively mitigate incidence AB cases safeguarding public health eliminate dog mediated rabies 2030 region",
        "mesh_terms": [
            "Humans",
            "Bites and Stings",
            "Bangladesh",
            "Male",
            "Animals",
            "Child",
            "Adolescent",
            "Female",
            "Rabies",
            "Child, Preschool",
            "Retrospective Studies",
            "Adult",
            "Young Adult",
            "Infant",
            "Middle Aged",
            "Spatio-Temporal Analysis",
            "Incidence",
            "Dogs",
            "Seasons",
            "Post-Exposure Prophylaxis",
            "Rabies Vaccines",
            "Aged",
            "Cats"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40489552/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40463970",
        "title": "In-hospital mortality among hospitalized COVID-19 patients in a tertiary care hospital in Dhaka City: a retrospective cohort study.",
        "abstract": "Inhospital mortality COVID19 treatment crucial metric used assess severity disease effectiveness medical interventions identifying mortality risk factors aim inform policy decisions optimize resource allocation improve preparedness future pandemics retrospective cohort study conducted tertiary hospital Dhaka City Bangladesh Data gathered hospitals electronic medical record July 2021 September 2021 applying specific inclusion exclusion criteria 218 patient complete medical record selected analysis independent variable examined included demographic characteristics comorbidities clinical features assess inhospital mortality relative risk RR 95 confidence interval calculated using multivariable logistic regression analysis employing Delta method study included 218 hospitalized COVID19 patients primarily male 514 average age 564 year standard deviation 15 years overall inhospital mortality rate 183 Older age ≥60 RR310 95 CI 116829 longstanding hypertension ≥5 years RR278 95 CI154502 chronic kidney disease CKD RR443 95 CI293670 significant risk factor mortality Patients diabetes ≥3 years moderately increased risk RR168 95 CI 101283 Notably shorter hospital stay ≤7 days associated higher mortality potentially due delayed treatment initiation Moreover Vaccinated patient significantly lower risk death RR 007 compared unvaccinated patients highlighting protective effect vaccination Greater lung involvement especially lower lobes higher Total Severity Scores TSS ≥ 14 strongly predict COVID19 mortality nonsurvivors exhibiting significantly worse radiographic damage Age particularly combined chronic condition like hypertension chronic kidney disease key predictor inhospital COVID19 mortality gender independent risk factor male tend higher mortality rates Delayed treatment reflected shorter hospital stays also increase risk Vaccination markedly lower mortality resourcelimited settings lower lobe involvement 50 TSS ≥ 14 serve early triage marker guide ICU admission intensified care indicator inform risk assessment tools resource allocation targeted intervention reduce pandemicrelated mortality",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40463970/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40463439",
        "title": "Azithromycin treatment response as a probe to attribute bacterial etiologies of diarrhea using molecular diagnostics: a reanalysis of the Antibiotics for Children with Severe Diarrhea (ABCD) trial.",
        "abstract": "Multipathogen molecular diagnostics enhance understanding pathogenspecific burden diarrhea However attributing etiology remains challenging highburden setting coinfections common Antibiotics Children severe Diarrhea ABCD trial provides unique opportunity leverage azithromycin treatment response identify bacterial diarrhea analyzed data 6692 child watery diarrhea enrolled ABCD 2017 2019 randomized receive azithromycin placebo modelled heterogeneity azithromycin treatment response enteric pathogen quantity detected quantitative PCR using logbinomial regression Azithromycin treatment response varied pathogen quantity strongest effect observed iShigellai log₁₀ increase iShigellai quantity associated 13 reduction 95 CI 323 diarrhea risk day 3 azithromycin group compared placebo observed similar though nonsignificant trend iVibrio choleraei STETEC tEPEC contrast association found pathogen quantity azithromycin response iCampylobacteri LTETEC EAEC pattern remained consistent evaluating hospitalization death risk within 90 days observed association azithromycin treatment response pathogen quantity iShigellai iVibrio choleraei STETEC tEPEC support prior evidence pathogen likely cause diarrhea present high quantities Conversely absence similar response pattern iCampylobacteri LTETEC EAEC consistent largescale study showing limited association quantity diarrhea",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40463439/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40463364",
        "title": "An integrated mutation-based immunoinformatic approach incorporating variability in epitopes: a study based on HIV subtype C.",
        "abstract": "Currently HIV human immunodeficiency virus infection one leading complication public health cause acquired immunodeficiency syndrome AIDS especially African region specific vaccine available combat this multistrain variability one hurdles investigation employed variability epitope HIV subtype C target introduce mutation construct epitopebased vaccine Four target examined predict B cell major histocompatibility complex class II Among predicted epitopes immunodominant epitope selected mapped identified variable amino acid incorporate mutation selected mutated epitope used nonmutated mutated vaccine construction considering linker fusion adjuvant improve activity vaccines structure modeled examined validate structural quality high population coverage also found docking investigation nonmutated mutated vaccine Tolllike receptor 3 show remarkable activity followed strong binding affinity simulation 100 n revealed constancy complex system immune response revealed strong effectiveness generating multiple immunoglobulin followed time step infection further iin silicoi cloning demonstrated high expression iEscherichia colii based favorable Codon Adaptation Index GC value integrated approach investigation help plan potent immunodominant vaccine work multiple strain HIV infection",
        "mesh_terms": [
            "Humans",
            "HIV-1",
            "HIV Infections",
            "Mutation",
            "AIDS Vaccines",
            "Computational Biology",
            "Epitopes, T-Lymphocyte",
            "Immunodominant Epitopes",
            "Molecular Docking Simulation",
            "Epitopes, B-Lymphocyte"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40463364/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40460588",
        "title": "Post-mortem study of endemic human coronaviruses (HCoV-NL63, OC43, 229E and HKU-1) in deaths of children under five in low- and middle-income countries: Findings from the Child Health and Mortality Prevention Surveillance (CHAMPS) study.",
        "abstract": "Endemic human coronaviruses HCoV229E HKU1 NL63 OC43 common cause mild asymptomatic respiratory infection child considered rare cause death evaluated pediatric death January 2017 December 2022 panel expert determined cause death CoD reviewing available data including pathological molecular finding minimally invasive tissue sampling lung tissues blood CSF nasopharyngeal swabs clinical records verbal autopsies Endemic HCoV detected respiratory sample 3  n  863357 enrolled decedents 1  n  122043 neonates 5  n  35681 infant 6  n  39633 child deaths However HCoVs attributed CoD two case  involving young infant underlying birth defect severe wasting succumbed polymicrobial hospitalacquired infection involving HCoVOC43 Klebsiella pneumoniae Acinetobacter baumannii Amongst remaining 84 decedent HCoV detected 82  n  6984 median Ct 2534 range 15283617 death attributed infections including 54  n  3269 median Ct 2386 range 1528352 lower respiratory infection determined CoD bulk death 96  n  6669 attributed pathogen  Plasmodium falciparum 27  n  1969 K pneumoniae 23  n  1669 Streptococcus pneumoniae 20  n  1469 Escherichia coli 16  n  1169 Cytomegalovirus 10  n  769 Although endemic HCoV identified child died respiratory infections rarely attributed CoD Nevertheless research warranted explore potential role HCoVs LRTI pathogenesis impact facilitating pathogenic infections",
        "mesh_terms": [
            "Humans",
            "Infant",
            "Coronavirus Infections",
            "Child, Preschool",
            "Infant, Newborn",
            "Male",
            "Female",
            "Autopsy",
            "Respiratory Tract Infections",
            "Coronavirus",
            "Cause of Death",
            "Developing Countries",
            "Coronavirus OC43, Human",
            "Coronavirus NL63, Human",
            "Coronavirus 229E, Human"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40460588/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40449873",
        "title": "Global dengue epidemic worsens with record 14 million cases and 9000 deaths reported in 2024.",
        "abstract": "Dengue caused dengue virus DENV fastestgrowing mosquitoborne disease worldwide utilised monthly data dengue case death reported World Health Organisations WHO global surveillance system period 1supstsup January 31supstsup December 2024 performed generalised linear regression model understand countrylevel determinant denguerelated mortality 2024 141 million dengue case reported globally surpassing historic milestone 7 million observed 2023 figure represents twofold increase compared 2023 12fold rise compared 2014 n1206644 2024 9508 denguerelated death recorded resulting global casefatality rate 007 regression analysis country Southern hemisphere incidence rate ratio IRR 595 95 CI 419846 aged population IRR 104 CI 101107 mean annual temperature IRR 121 CI 116126 significantly associated higher denguerelated mortality per million population ongoing dengue outbreak underscore urgent need global investment DENV research vaccine development vector control therapeutic strategies urge inclusion DENV WHOs Research Development Priority Disease list address growing global health threat",
        "mesh_terms": [
            "Humans",
            "Dengue",
            "Global Health",
            "Dengue Virus",
            "Epidemics",
            "Adolescent",
            "Incidence",
            "Adult",
            "Child",
            "Middle Aged",
            "Child, Preschool",
            "Female",
            "Male",
            "Young Adult",
            "Infant",
            "Aged",
            "World Health Organization"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40449873/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40437297",
        "title": "A One Health approach to understanding and managing Nipah virus outbreaks.",
        "abstract": "Nipah virus NiV zoonotic paramyxovirus belonging genus Henipavirus infects Pteropus bat specie Southeast South Asia Since discovery late 1990s Malaysia NiV caused outbreak human Singapore Bangladesh India Philippines spillover pathway recent NiV outbreak 2023 Kerala India remains speculative NiV cause serious disease infected humans mean casefatality rate 70 approved treatment vaccine exist Humans infected directly bat shared food infected bridging hosts including pig horses although spillover pathway may exist Here review pathway NiV spillover transmission highlighting area needing research emphasize importance collaborative multidisciplinary effort laboratory field implementation One Health strategy prevent future epidemics",
        "mesh_terms": [
            "Henipavirus Infections",
            "Nipah Virus",
            "Animals",
            "Humans",
            "Disease Outbreaks",
            "Chiroptera",
            "One Health",
            "Zoonoses",
            "Swine",
            "Viral Zoonoses",
            "Horses"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40437297/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40432708",
        "title": "Environmental Health Risk Evaluation and Potential to Cause Disease X as a Global Pandemic: A Call for Global Preparedness.",
        "abstract": "Emerging infectious disease pose constant threat global health economy Among them concept disease X emerged owing uncertainty identity pathogen may cause next pandemic Disease X gained significant attention due potential cause public health emergency future study aimed investigate disease X identify key risk factor leading emergence spread propose strategy prevent future global pandemics performed comprehensive literature review identified relevant information study Pandemic public health emergency infectious disease used keywords literature search study indicates disease X could lifethreatening global pandemic Among various risk factors climate change increased animalhuman contact emergence antibiotic resistance risk factor may lead pandemic help transmission zoonotic infections Here discussed potential pathogens including bacteria viruses fungi capable causing disease X Finally indicated necessary measure required prevention management future global pandemic Disease X already posed substantial threat global health system warranting urgent attention action Comprehensive preparedness measures including robust surveillance systems early detection vaccine development essential mitigating risk posed disease X Collaboration among healthcare organizations research communities government body essential resilience future pandemics",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40432708/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40432698",
        "title": "Risk Evaluation and Mitigation Strategies for Newly Detected Mysterious Dinga Dinga Virus Infection in Africa: A Narrative Review.",
        "abstract": "Dinga Dinga Virus DDV emerged mysterious disease gripping woman Uganda raising alarm due unusual distressing dancing like symptoms symptoms characterized involuntary movement resembling dance suggest possible neurological involvement though exact pathogen remains unidentified causative agent DDV still unknown hypothesized possible microorganism could virus bacteria vectorborne origin Therefore comprehensive research urgently needed confirm cause performed comprehensive literature search Scopus Web Science related different outbreak viruses collected relevant information appropriate article review unique representation disease spreading rapidly localized area potential escalate broader public health crisis Preventive measure focused symptom monitoring public awareness isolation suspected case limit transmission Authorities emphasize hygiene practices using personal protective equipment PPE early reporting manage outbreak effectively Simultaneously global health organization called collaborate diagnostic development therapeutic interventions vaccine research disproportionate impact woman brought social cultural dynamic spotlight stigma misinformation exacerbate outbreaks challenges Immediate longterm strategy must address aspect strengthening healthcare infrastructure enhancing disease surveillance systems world recovers COVID19 pandemic DDV stark reminder ongoing threat emerging infectious diseases Proactive sciencedriven effort critical understanding mitigating enigmatic disease ensuring escalate another global health crisis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40432698/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40430433",
        "title": "Systems Biology-Driven Discovery of Host-Targeted Therapeutics for Oropouche Virus: Integrating Network Pharmacology, Molecular Docking, and Drug Repurposing.",
        "abstract": "bBackgroundb Oropouche virus OROV part Peribunyaviridae family emerging pathogen causing Oropouche fever febrile illness endemic South Central America Transmitted primarily midge bite iCulicoides paraensisi OROV specific antiviral treatment vaccine study aim identify hosttargeted therapeutic OROV using computational approaches offering potential strategy sustainable antiviral drug discovery bMethodsb Virusassociated host target identified using OMIM GeneCards databases Enrichr DSigDB platform used drug prediction filtering compound based Lipinskis rule drug likeness proteinprotein interaction PPI network analysis conducted using STRING database Cytoscape 3103 software Four key host targetsIL10 FASLG PTPRC FCGR3Awere prioritized based role immune modulation OROV pathogenesis Molecular docking simulation performed using PyRx software evaluate binding affinity selected smallmolecule inhibitorsAcetohexamide Deptropine Methotrexate Retinoic Acid 3Azido3deoxythymidineagainst identified targets bResultsb PPI network analysis highlighted immunemediated pathway Fcgamma receptor signaling cytokine control Tcell receptor signaling critical intervention points Molecular docking revealed strong binding affinity selected compound prioritized targets suggesting potential efficacy hosttargeting antiviral candidates Acetohexamide Deptropine showed strong binding multiple targets indicating broadspectrum antiviral potential vitro vivo validation needed confirm finding translate clinically relevant treatments bConclusionsb study highlight potential using computational approach identify hosttargeted therapeutic Oropouche virus OROV targeting key host protein involved immune modulationIL10 FASLG PTPRC FCGR3Athe selected compounds Acetohexamide Deptropine demonstrate strong binding affinities suggesting potential broadspectrum antiviral candidates experimental validation needed confirm efficacy potential clinical application offering promising strategy sustainable antiviral drug discovery",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40430433/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40424392",
        "title": "\"Everything had stopped, no meeting, no gathering\": Social interactions during the COVID-19 pandemic in the Central African Republic, the Democratic Republic of Congo, and Bangladesh.",
        "abstract": "Understanding spread COVID19 humanitarian fragile setting challenging many reasons including lack data social dynamic preventive behavior epidemic investigate social interaction three setting  Democratic Republic Congo DRC Central African Republic CAR Coxs Bazar CXB Bangladesh  changed first year pandemic comparative mixedmethods study us representative household survey focus group discussion key informant interview site Descriptive weighted analysis survey response conducted multivariate logistic regression identified factor associated change social interactions Thematic analysis conducted qualitative data Nearly participant social interaction day survey although average number daily interaction low Interactions primarily occurred indoors home without masks saw discrepancy knowledge practice preventive behaviors respondent reported interacting less often 773 CXB 867 CAR 588 DRC shorter meeting 80 CXB 778 CAR 478 DRC Reluctance towards COVID19 vaccine risk factor noncompliant behavior CAR OR increased frequency  351 95CI  141875 increased duration  247 95CI  115529 DRC OR increased duration  306 95CI  171549 likely pointing distrust towards institutional policies Respondents IDP community DRC less likely reduce frequency interaction likely living condition facilitate physical distancing Increased knowledge CXB associated compliant behavior for 1ptincrease increased frequency  047 95CI  032068 increased duration  046 95CI  031069 Understanding social dynamic fundamental predict infectious disease spread particularly humanitarian settings evidence needed understand behavior influencing disease dynamic driver behaviors including trust authorities social economic factors Peace community engagement reduction misinformation remain critical epidemic response humanitarian settings",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "Democratic Republic of the Congo",
            "Female",
            "Male",
            "Bangladesh",
            "Adult",
            "Middle Aged",
            "Pandemics",
            "Social Interaction",
            "SARS-CoV-2",
            "Young Adult",
            "Surveys and Questionnaires",
            "Adolescent",
            "Focus Groups"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40424392/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40421764",
        "title": "Poxvirus pathology and pathogenesis in agriculturally important species.",
        "abstract": "Zoonotic poxviruses including monkeypox virus MPV causative agent Mpox disease gained significant medium scientific attention due recent outbreak human population across globe increase human case poxvirus infection unexpected routine vaccination smallpox a disease caused poxvirus variola virus cross protects orthopoxviruses discontinued 1980s eradication Large number vertebrate invertebrate specie susceptible infection iPoxviridaei Clinical sign histologic lesion caused genetically different poxvirus strikingly similar notable exception eg poxviral infection fish purpose article review poxvirus pathology pathogenesis observed specie agricultural significance including poultry cattle goats sheep camels swine rabbits horses salmon carp",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40421764/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40419097",
        "title": "Foot-and-mouth disease virus O/ME-SA/SA-2018: A new emerging threat posed by viruses circulating in Asia?",
        "abstract": "2018 novel lineage footandmouth disease virus FMDV termed OMESASA2018 identified India subsequently spread neighbouring country Nepal Bangladesh Sri Lanka Since then incursion lineage occurred Middle East beyond usual epidemiological distribution Using sequence data derived field cases paper reconstructs evolutionary history OMESASA2018 lineage present vaccine matching data six commercially available FMD vaccines describes novel lineagespecific RTPCR assay used help detect field case due emerging lineage surveillance study warranted understand distribution virus Asian countries",
        "mesh_terms": [
            "Foot-and-Mouth Disease Virus",
            "Foot-and-Mouth Disease",
            "Animals",
            "Asia",
            "Phylogeny",
            "Communicable Diseases, Emerging",
            "Viral Vaccines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40419097/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40412396",
        "title": "Health-care burden related to respiratory syncytial virus in a resource-constrained setting: a prospective observational study.",
        "abstract": "Respiratory syncytial virus RSV leading cause paediatric hospital admission worldwide straining health systems lack data burden RSV infection impact health system resourcelimited setting hinders evidencebased policy decisions Here aimed assess RSVs burden health system Bangladesh January December 2019 conducted prospective study Bangladeshs largest paediatric hospital among child aged 059 month admitted possible respiratory infection guided RSV hospitalbased surveillance case definition Outcomes RSVpositive child younger 5 year analysed also followed outcome child denied hospitalisation due bed shortages Adjusted hazard ratio child denied admission versus admitted estimated using survival analysis Monte Carlo simulation queueing model used estimate effect RSV prefusion F maternal vaccine nirsevimab admission denial mortality 40 664 child admitted 31 692 younger 5 years 19 940 study wards Among 7191 admitted possible respiratory infections 6149 85·5 nasopharyngeal swab taken 1261 20·5 testing RSVpositive median age child tested positive RSV 3·0 month IQR 1·08·0 median hospital stay 5 day IQR 48 24 1·9 1261 died hospital 8274 5·5 151 110 bed day child positive RSV Additionally 9169 child denied admission outcome tracked 3928 compared 2845 admitted hazard ratio death 1·56 95 CI 1·34 1·81 child denied versus admitted highest neonate 2·27 1·87 2·75 RSV prefusion F maternal vaccine nirsevimab could reduced denial 677 95 prediction interval 63 1347 1289 684 1865 respectively potentially preventing 130 60 322 258 32 469 deaths RSV strain health care Bangladesh increasing mortality risks Preventive intervention could lessen impact boosting healthcare capacity child health resourcelimited settings Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Humans",
            "Respiratory Syncytial Virus Infections",
            "Prospective Studies",
            "Infant",
            "Child, Preschool",
            "Female",
            "Bangladesh",
            "Male",
            "Infant, Newborn",
            "Hospitalization",
            "Cost of Illness",
            "Health Resources"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40412396/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40380137",
        "title": "Science tikkun: a bioscience pandemic framework in a Hebrew tradition of global repair.",
        "abstract": "past decade seen steady increase dangerous pandemic threats include two major Ebola epidemic cholera Africa dengue Zika yellow fever Americas COVID19 pandemic H5N1 Texas happening confluence modern force including urbanization deforestation climate change Yet pandemic emerge crowded warming planet antiscience disinformation antisemitism impede response Science tikkun overarching framework repair redress honor legacy Maimonides Teilhard de Chardin others sought reconciliation science religion",
        "mesh_terms": [
            "Humans",
            "Pandemics",
            "COVID-19",
            "SARS-CoV-2"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40380137/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40377940",
        "title": "Adherence to Perinatal Asphyxia or Sepsis Management Guidelines in Low- and Middle-Income Countries.",
        "abstract": "23 million annual neonatal death occur subSaharan Africa South Asia perinatal asphyxia neonatal sepsis leading cause neonatal mortality neonatal death considered preventable highquality clinical care includes adherence clinical care guidelines assess adherence World Health Organization clinical care guideline management perinatal asphyxia neonatal sepsis identify patientlevel factor adherence among neonate died conditions crosssectional study obtained data December 2015 October 2023 Child Health Mortality Prevention Surveillance CHAMPS catchment area 7 low middleincome country subSaharan Africa Ethiopia Kenya Mali Mozambique Sierra Leone South Africa South Asia Bangladesh Participants neonate born alive aged 0 28 day time death either perinatal asphyxia neonatal sepsis Medical record neonate died perinatal asphyxia neonatal sepsis determined postmortem diagnostics main outcome proportion deceased neonate received guidelineadherent treatment died Mixedeffect multivariable logistic regression analysis performed identify factor associated administration least bagvalvemask BVM ventilation perinatal asphyxia 1194 neonate median IQR age time death 2 16 days 692 male 580 died enrolled CHAMPS available clinical data 476 399 died perinatal asphyxia 562 470 died neonatal sepsis 156 131 conditions neonate median IQR birth weight 2130 12662988 g case perinatal asphyxia guideline adherence ranged 122 n  77 adrenaline administration 854 540 supplemental oxygen administration 44 neonate 28 perinatal asphyxia received recommended treatments Among case neonatal sepsis antibiotic administered 868 623 although recommended treatment administered 610 438 multivariable analyses neonate clinician accurately identified perinatal asphyxia likely receive BVM ventilation received discordant antemortem postmortem diagnosis adjusted odds ratio 200 95 CI 129312 crosssectional study clinical care guideline adherence suboptimal among neonate died perinatal asphyxia neonatal sepsis finding underscore critical need increase adherence region high rate neonatal mortality may inform strategy strengthening health system support compliance clinical care guidelines",
        "mesh_terms": [
            "Humans",
            "Infant, Newborn",
            "Asphyxia Neonatorum",
            "Guideline Adherence",
            "Cross-Sectional Studies",
            "Male",
            "Female",
            "Developing Countries",
            "Neonatal Sepsis",
            "Sepsis",
            "Africa South of the Sahara",
            "Practice Guidelines as Topic",
            "Infant Mortality",
            "Infant"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40377940/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40355819",
        "title": "Bioinformatics-guided decoding of the Ancylostoma duodenale genome for the identification of potential vaccine targets.",
        "abstract": "Ancylostoma duodenale parasitic nematode worm found involved various infections including intestinal blood loss protein malnutrition anemia Antimicrobial resistance available therapeutic prompted search new drug vaccine target A duodenale Despite significant advance vaccine development A duodenale commercial FDAapproved vaccine exists safeguard human infection caused pathogen investigation stringent bioinformatics analysis identified 36 unique essential hostinteracting proteins Based subcellular localization 6 protein located extracellular space outer membrane categorized vaccine targets remaining protein predicted act potential drug candidates vaccine candidate assessed antigenicity allergenicity physicochemical analysis determine suitability designing multiepitope vaccine Two candidate protein chosen optimal target development vaccine design identified T Bcell epitope protein combined appropriate linkers adjuvant design chimeric vaccine construct aimed inducing cellular humoral immune responses Molecular docking molecular dynamic simulations PCA analysis DCCM analysis binding free energy calculation proved stable interaction designed vaccine human immune cell receptors Within bacterial cloning system vaccine construct demonstrated ability cloned expressed immunological stimulation elicited significant immunological response proposed vaccine investigation identified new therapeutic target developed peptidebased multiepitope vaccine A duodenale infection Additional experimental verification open new therapeutic alternative emerging resistant pathogen",
        "mesh_terms": [
            "Computational Biology",
            "Ancylostoma",
            "Animals",
            "Molecular Docking Simulation",
            "Vaccines",
            "Humans",
            "Epitopes, T-Lymphocyte",
            "Helminth Proteins",
            "Epitopes, B-Lymphocyte",
            "Molecular Dynamics Simulation"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40355819/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40335470",
        "title": "Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019.",
        "abstract": "Chronic care manages longterm progressive conditions acute care address shortterm conditions Chronic condition increasingly strain health systems often unprepared demands study examines burden condition requiring acute versus chronic care including sequelae Conditions sequela Global Burden Diseases Study 2019 classified acute chronic care categories Data analysed age sex sociodemographic index presenting total number contribution burden metric DisabilityAdjusted Life Years DALYs Years Lived Disability YLD Years Life Lost YLL Approximately 68 DALYs attributed chronic care 27 due acute care Chronic care need increased age representing 86 YLDs 71 YLLs accounting 93 YLDs sequelae finding highlight chronic care need far exceed acute care need globally necessitating health system adapt accordingly",
        "mesh_terms": [
            "Humans",
            "Chronic Disease",
            "Female",
            "Male",
            "Global Burden of Disease",
            "Middle Aged",
            "Aged",
            "Adult",
            "Disability-Adjusted Life Years",
            "Young Adult",
            "Aged, 80 and over",
            "Health Services Needs and Demand",
            "Adolescent",
            "Acute Disease",
            "Persons with Disabilities",
            "Child",
            "Child, Preschool",
            "Infant",
            "Cost of Illness"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40335470/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40333874",
        "title": "Immunization status of children with cerebral palsy: A cross-sectional hospital-based study in Vietnam.",
        "abstract": "describe immunization status child CP Vietnam identify factor associated vaccine nonuptake group conducted active prospective case ascertainment child cerebral palsy CP attending National Childrens Hospital Hanoi June November 2017 following model proposed Paediatric Active Enhanced Disease Surveillance system Australia child assessed trained paediatrician hospital immunization history recorded Data collected 765 child CP median age  17 years IQR  27 years children 827 fully immunized age compared 964 general child population according Vietnamese Expanded Programme Immunization EPI schedule BCG vaccination scar present 940 child CP 959 eligible child received measlesrubella vaccine part national campaign compared 960 982 general population respectively Incomplete vaccination according EPI associated younger age living earthsand house homebirth lowlevel maternal education diagnosed CP age three bilateral CP associated impairment ie epilepsy intellectual visual speech level IVV Gross Motor Function Classification System undernutrition first study document immunization status child CP Vietnam large proportion received measlesrubella vaccine 173 fully immunized increase vaccination coverage intervention strategy required ensure child CP equitable access early diagnosis immunization health education programs outreach programs frequent followup Early diagnosis focused intervention early life could improve vaccination coverage child CP",
        "mesh_terms": [
            "Humans",
            "Cerebral Palsy",
            "Vietnam",
            "Female",
            "Male",
            "Child, Preschool",
            "Infant",
            "Cross-Sectional Studies",
            "Child",
            "Vaccination",
            "Prospective Studies",
            "Immunization Programs",
            "Immunization",
            "Hospitals"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40333874/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40322786",
        "title": "Cost-effectiveness of a behavioral insights-informed digital campaign to increase HPV vaccination in Bangladesh.",
        "abstract": "Digital platform like social medium increasingly used promote vaccine uptake low middleincome country LMICs yet limited evidence exists economic value study estimate costeffectiveness behavioral insightsinformed social medium campaign designed increase HPV vaccine uptake among adolescent girl age 914 Bangladesh static costeffectiveness analysis conducted health system perspective Inputs included campaign delivery costs vaccine procurement distribution treatment cost averted cervical cancer prevention Disabilityadjusted life year DALYs averted per vaccinated girl modeled using global burdenofdisease parameters Effectiveness estimate drawn quasiexperimental evaluation campaign reported 95 percentagepoint increase vaccine uptake one study arm 53 percentagepoint increase another relative control group finding preceded posttest study Dhaka Division showed strong association campaign exposure vaccination behavior incremental cost per vaccinated girl 602 cost per DALY averted  ie Incremental CostEffectiveness Ratio ICER  3957 fall well established costeffectiveness thresholds including 40 GDP per capita commonly applied LMICs finding suggest digital campaign guided behavioral insight represent highly costeffective approach addressing persistent immunization coverage gaps result support integration strategy national immunization programs particularly context traditional outreach method may face financial constraints",
        "mesh_terms": [
            "Humans",
            "Female",
            "Cost-Benefit Analysis",
            "Bangladesh",
            "Adolescent",
            "Papillomavirus Vaccines",
            "Papillomavirus Infections",
            "Uterine Cervical Neoplasms",
            "Child",
            "Vaccination",
            "Social Media",
            "Health Promotion",
            "Immunization Programs",
            "Disability-Adjusted Life Years"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40322786/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40322557",
        "title": "Evaluation of Immunostimulatory Effects of Bacterial Lysate Proteins on THP-1 Macrophages: Pro-inflammatory Cytokine Response and Proteomic Profiling.",
        "abstract": "Bacterial lysate protein BLPs serve potential immunostimulants recognized pattern recognition receptor PRRs immune cells eliciting robust immune response study THP1 macrophage treated varying dos BLPs derived iStreptococcus pyogenesi SP iStreptococcus agalactiaei SA iSerratia marcescensi SM result showed significant increase ipi  005 proinflammatory cytokine TNFiαi IL1iβi IL6 IL12 granulocyte macrophagecolony stimulating factor GMCSF eotaxin macrophage inflammatory protein MIP1iαi except 5 µg BLPs TNFiαi eotaxin 5 µg SP IL12 production significant difference found corresponding dos SP SA SP SM except GMCSF doses SA SM showed difference 5 µg dose GMCSF Furthermore significant difference 10 20 µg dos BLPs indicating dos higher 10 µg significantly enhance proinflammatory response Combination dos SP  SM SA  SM show significant differences except IL1iβi suggesting synergistic effect Cytotoxicity observed increase higher BLP concentration dosedependent manner combination SP  SM SA  SM exhibiting greater cytotoxicity individual BLPs Proteomic analysis BLPs identified immunostimulatory proteins including heat shock protein HSPs ClpB DnaK GroEL metabolic enzyme glyceraldehyde 3phosphate dehydrogenase GAPDH enolase arginine deiminase ADI surface secreted protein ESAT6like protein CRISPRassociated endonuclease Cas9 OmpA porin OmpC serralysin involved immune modulation bacterial clearance immune evasion study underscore potential bacterial protein vaccine adjuvant supplementary therapies however research essential find balance immune activation inflammation reduction develop safer effective immunostimulants",
        "mesh_terms": [
            "Humans",
            "Macrophages",
            "Cytokines",
            "Proteomics",
            "Bacterial Proteins",
            "THP-1 Cells",
            "Streptococcus pyogenes",
            "Adjuvants, Immunologic",
            "Inflammation Mediators",
            "Streptococcus agalactiae",
            "Proteome",
            "Bacterial Lysates"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40322557/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40318346",
        "title": "Consultation report - considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries.",
        "abstract": "Enteric fever caused Salmonella enterica serovars Typhi Paratyphi and lesser extent S Paratyphi B C remains significant cause mortality morbidity resourceconstrained settings Typhoid conjugate vaccine TCVs protect S Typhi vaccine date protects paratyphoid fever several bivalent S TyphiParatyphi product development however low incidence paratyphoid fever many setting limit feasibility phase 3 efficacy studies Two bivalent vaccine adding S Paratyphi Aspecific O2 lipopolysaccharide conjugated protein carrier TCV construct successfully completed phase 1 study progress rapidly development WHOs Product Development Vaccines Advisory Committee PDVAC endorsed regulatory pathway bivalent S TyphiParatyphi vaccine contemplates demonstrating protective efficacy S Paratyphi infection controlled human infection model CHIM Since use CHIM data lieu phase 3 efficacy study identify marker immune protection yet widely accepted regulatory bodies organized consultation vaccine developers manufacturers regulators purpose meeting discus feasibility consideration licensure bivalent S TyphiParatyphi vaccine aim consultation gain alignment among key stakeholder facilitate pathway licensure endemic countries",
        "mesh_terms": [
            "Typhoid-Paratyphoid Vaccines",
            "Humans",
            "Salmonella typhi",
            "Typhoid Fever",
            "Salmonella paratyphi A",
            "Paratyphoid Fever",
            "World Health Organization",
            "Endemic Diseases",
            "Vaccine Development",
            "Advisory Committees",
            "Vaccines, Conjugate"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40318346/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40316604",
        "title": "Computational analysis of lupenone derivatives as potential inhibitor of human papillomavirus oncoprotein E6 associated cervical cancer.",
        "abstract": "Cervical cancer remains major global health challenge largely driven persistent infection highrisk human papillomavirus HPV Although preventive vaccine reduced cervical cancer incidence settings effective therapeutic strategy established HPVassociated malignancy remain limited Highrisk HPV type particularly 16 18 utilize E6 oncoprotein promote ubiquitinmediated degradation tumor suppressor p53 thereby facilitating uncontrolled cell proliferation immune evasion Targeting E6 thus emerged key strategy counteract HPVdriven carcinogenesis work employed comprehensive silico frameworkencompassing density functional theory DFT ADMET absorption distribution metabolism excretion toxicity profiling molecular docking including refinement validation molecular dynamic MD simulationsto evaluate series chemically modified lupenone derivative potential HPV oncoprotein inhibitors Initially lupenone modified different functional groups derivative screened druglikeness via ADMET analysis confirm pharmacological viability Concurrently pharmacophore mapping highlighted key alignment ligand functional group pharmacophoric sites DFT calculation elucidated compounds electronic structure conformational stability chemical reactivity Subsequent docking assessment E6 oncoprotein molecular dynamic simulation confirmed structural robustness several topperforming compounds indicating minimal conformational fluctuation time finding demonstrate potential lupenone derivative promising scaffold antiHPV therapy However vitro vivo investigation necessary confirm efficacy toxicity profiles clinical relevance mitigating HPVrelated cervical cancer",
        "mesh_terms": [
            "Humans",
            "Uterine Cervical Neoplasms",
            "Female",
            "Oncogene Proteins, Viral",
            "Molecular Docking Simulation",
            "Molecular Dynamics Simulation",
            "Papillomavirus Infections",
            "Repressor Proteins",
            "Human papillomavirus 16",
            "Human Papillomavirus Viruses"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40316604/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40309315",
        "title": "Human papillomavirus in Bangladesh: Challenges and opportunities for prevention.",
        "abstract": "•Cervical cancer second leading cause cancerrelated death among female Bangladesh•Despite progress vaccination HPVrelated health challenge persist due limited vaccine access low public awareness emerging viral strains",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40309315/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40305928",
        "title": "Advances and challenges in cancer immunotherapy: Strategies for personalized treatment.",
        "abstract": "Cancer immunotherapy transformed oncology harnessing immune system specifically target cancer cells offering reduced systemic toxicity compared traditional therapies review highlight key strategies including adoptive cell transfer ACT immune checkpoint inhibitors oncolytic viral OV therapy monoclonal antibody mAbs mRNAbased vaccines ACT reinfuses enhanced immune cell like tumorinfiltrating lymphocyte TILs combat refractory cancers checkpoint inhibitor eg PD1 CTLA4 blockers restore Tcell activity OV therapy us engineered virus eg TVEC selectively lyse cancer cells advanced mAbs improve targeting precision mRNA vaccine introduce tumorspecific antigen trigger robust immune responses Despite significant progress challenge like immunerelated side effects high costs immunosuppressive tumor microenvironments persist review underscore need combination strategy precision medicine overcome barrier maximize potential immunotherapy personalized cancer treatment",
        "mesh_terms": [
            "Humans",
            "Neoplasms",
            "Precision Medicine",
            "Immunotherapy",
            "Cancer Vaccines",
            "Tumor Microenvironment",
            "Oncolytic Virotherapy",
            "Immune Checkpoint Inhibitors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40305928/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40303072",
        "title": "<i>In Silico</i> Driven Multi-Epitope Subunit Candidate Vaccine against Bovine Tuberculosis.",
        "abstract": "Bovine tuberculosis bTB caused iMycobacterium bovisi pose significant zoonotic economic challenge globally current prevention treatment option limited increasingly complicated emergence multidrugresistant strains study employ reverse vaccinology immunoinformatics design multiepitope subunit vaccine targeting MPB83 ArfA DnaK GrpE LpqH protein iM bovisi Tcell Bcell epitope candidate vaccine predicted evaluated antigenicity allergenicity toxicity promising epitope assembled three vaccine construct bTBV1 bTBV2 bTBV3 using appropriate adjuvants pan HLA DRbinding epitope PADRE linkers construct analyzed physicochemical properties 3D structure cytokine induction stability followed molecular docking bovine CD molecule tolllike receptor TLR9 Among candidates bTBV3 chosen one promising vaccine candidate due high aliphatic index 6760 lowest instability score 2726 strong binding affinity Molecular dynamic simulation result interaction vaccinereceptor complex eigenvalue 2318704e06 show vaccine construct bTBV3 stable iIn silicoi immune simulation findings elevated IgM level increased Th cell populations suggest designed multiepitope vaccine candidate bTBV3 elicits robust humoral cellular immune responses confirming vaccines potential efficacy Additionally codon optimization CAI 0997 GC 54687 iin silicoi cloning facilitated efficient expression iE colii study highlight potential bioinformaticsdriven approach developing effective subunit vaccine bTB providing foundation experimental validation future application combating pervasive zoonotic disease bovine tuberculosis",
        "mesh_terms": [
            "Animals",
            "Cattle",
            "Tuberculosis Vaccines",
            "Vaccines, Subunit",
            "Tuberculosis, Bovine",
            "Mycobacterium bovis",
            "Epitopes, B-Lymphocyte",
            "Epitopes, T-Lymphocyte",
            "Molecular Docking Simulation",
            "Computer Simulation",
            "Epitopes"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40303072/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40303052",
        "title": "Pathogenic Characteristics of Five Different Lineage of Korean PRRSV-2 Isolates (NADC30-Like, VR2332-Like, LKA, LKB, and LKC).",
        "abstract": "Porcine reproductive respiratory syndrome virus PRRSV significant pathogen worldwide swine industry virus show high genetic variation coupled broad range virulence pigs Although multiple lineage virus prevalent throughout Korea characteristic lineagewise pathogenicity largely unknown Therefore study designed analyze compare pathogenicity 11 representative Korean PRRSV2 isolates selected PRRSV2 lineage circulating Korea NADC30like VR2332like three nationspecific lineage lineage KOR LKA lineage KOR B LKB lineage KOR C LKC continuously prevalent nation Eleven group pig experimentally infected one Korean PRRSV2 isolate four consecutive animal experiments Body weight body temperature recorded 4week challenge experiment period virological serological histopathological test performed collected samples data animal experiment integrated two indicatorsexcretion clinical signsthrough correlation principal component analysis PCA Metaanalysis used compare PRRSV2 isolates using indicator Based analyses L1C virus used study JB15NP31GB JB15NPJ73GN similar NADC30like strains exhibited low moderate level excretion clinical signs lineage 5 L5 modified live vaccine MLVvariant strain exhibited high level excretion compared PRRSV2 isolates However L5 variant caused mild clinical signs except JB15NPJ4GN showed 4th highest clinical sign indicator Among Korean lineage LKA LKB LKC two LKB strain GGYC45 JB15NPJ10GN virulent showed highest mortality challenge hand LKA LKC virus displayed lower excretion indicator L5 strains higherranked clinical sign indicator lowvirulence L5 MLV variants conclusion PRRSV prevalent Korea diverse excretion clinical characteristics certain lineage highly pathogenic result offer useful insight prevent spread PRRSV improve efficacy vaccine future",
        "mesh_terms": [
            "Animals",
            "Swine",
            "Porcine respiratory and reproductive syndrome virus",
            "Porcine Reproductive and Respiratory Syndrome",
            "Republic of Korea",
            "Virulence",
            "Phylogeny"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40303052/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40295746",
        "title": "Toll-like receptor response to Zika virus infection: progress toward infection control.",
        "abstract": "Infection Zika virus ZIKV pose threat human health improved understanding host Tolllike receptor response disease onset viral clearance vivo vitro may lead development therapeutic prophylactic intervention viral infections Currently clinically approved ZIKV vaccine available highlighting need development study discus progress Zika vaccine including advance use Tolllike receptor agonist vaccine adjuvant enhance vaccine efficacy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40295746/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40290636",
        "title": "A Reverse Vaccinology and Immunoinformatic Approach for the Designing of a Novel mRNA Vaccine Against Stomach Cancer Targeting the Potent Pathogenic Proteins of <i>Helicobacter pylori</i>.",
        "abstract": "iHelicobacter pylorii infection stomachs epithelial cell significant risk factor stomach cancer Various iH pylorii protein CagA GGT NapA PatA urease VacA targeted design 2 messenger RNA mRNA vaccines V1 V2 using bioinformatics tools Physicochemical parameters secondary tertiary structure molecular docking dynamic simulation codon optimization RNA structure prediction also estimated developed vaccines Physicochemical analysis revealed developed vaccine soluble GRAVY  0 basic pI  7 stable aliphatic index  80 secondary tertiary structure vaccine demonstrated robustness docking tolllike receptor TLRs revealed vaccine potential affinity TLR2 V1 11323 kJmol V2 10936 kJmol TLR4 V1 10427 kJmol V2 12012 kJmol molecular dynamic simulation confirmed dynamic stability Structural analysis V1 50596 kcalmol V2 63492 kcalmol mRNA vaccine underscored stability addition vaccine showed considerable rise count B cell extended activation cell also observed vaccines suggesting potential longlasting immunity offering enhanced protection iH pylorii finding suggest potential longlasting immunity iH pylorii also offer hope future stomach cancer prevention Notably study emphasizes need subsequent animal humanbased study confirm promising results",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40290636/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40271995",
        "title": "Epidemiology and evolutionary dynamics of H9N2 avian influenza virus in Bangladesh.",
        "abstract": "Low pathogenicity avian influenza LPAI H9N2 enzootic Bangladeshi poultry since 2006 H9N2 outbreak decrease egg production growth pose risk human health role avian host persistence evolution dispersion H9N2 poorly understood Bangladesh Hence study unveils intricate role major host specie virus maintenance evolution temporal seasonal pattern H9N2 Bangladesh 2006 2023 Multinomial logistic regression analysis indicated circulation H9N2 different specie interface significantly influenced seasons Bayesian phylogenetic analysis H9N2 sequence Bangladesh revealed two distinct lineages G1 Eurasian G1 lineage split two clusters coexisting 2019 point one cluster persisted Bayesian phylodynamic analysis G1 lineage unveiled frequent bidirectional viral transition among ducks chickens quails Chickens might pivotal source H9N2 Bangladesh higher number viral transition chicken duck quails Quails appear acquire viral transition chicken rather ducks suggesting quail epizootics primarily triggered spillover event chickens result suggest viral circulation commercial chicken despite vaccination vaccination approach revised assess vaccine efficacy extension vaccination backyard chicken quails",
        "mesh_terms": [
            "Animals",
            "Bangladesh",
            "Influenza A Virus, H9N2 Subtype",
            "Influenza in Birds",
            "Chickens",
            "Phylogeny",
            "Poultry Diseases",
            "Ducks",
            "Evolution, Molecular",
            "Quail",
            "Bayes Theorem",
            "Humans",
            "Seasons"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40271995/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40267919",
        "title": "Advances and Challenges in Cervical Cancer: From Molecular Mechanisms and Global Epidemiology to Innovative Therapies and Prevention Strategies.",
        "abstract": "BackgroundIn global scenario public health cervical cancer pose major threat high mortality rates especially women New incidence case prevalence vary across different regions recently shown GLOBOCAN data development cervical cancer primarily due persistent infection highrisk genotype human papillomavirus HPV multifaceted process influenced genetic environmental lifestyle factorsPurposeThe goal study thoroughly investigate cervical cancer including etiology molecular mechanisms progression diagnosis strategies current therapies review highlight transformative power HPV vaccination screening program curbing diseases burden potentially promising novel approach like immunotherapy targeted therapyResearch DesignThis narrative review article summarizes previous literature regarding cervical cancer term molecular mechanism etiology clinical developments preventionStudy SampleThe review encompassed study diverse sources including experimental observational clinical research published 1992 2025Data Collection andor AnalysisData collected comprehensive literature search using database PubMed Scopus Cochrane Library defined inclusion exclusion criteriaResultsNonetheless gap research controversy regarding vaccine coverage screening practices treatment accessibility poor populations Precision medicine trend emerging along new biomarkers early detection personalized treatment also form part discussion Key finding include critical role prevention measure controlling global impact cervical cancerConclusionsThe paper synthesizes existing knowledge identifies gap require research significant augmenting prevention diagnosis treatment cervical cancer towards addressing public health implication worldwide",
        "mesh_terms": [
            "Humans",
            "Uterine Cervical Neoplasms",
            "Female",
            "Papillomavirus Infections",
            "Papillomavirus Vaccines",
            "Early Detection of Cancer",
            "Papillomaviridae",
            "Global Health"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40267919/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40267616",
        "title": "Neutralizing antibodies against the Japanese encephalitis virus are produced by a 12 kDa E. coli- expressed envelope protein domain III (EDIII) tagged with a solubility-controlling peptide.",
        "abstract": "Escherichia coli powerful costeffective platform producing recombinant proteins However E coli produced protein lack sidechain glycosylation may misfolded due nonnative disulfide bonds often leading poor immunogenicity result commonly perceived unsuitable use antiviral vaccine antigens study address challenge using small 12 kDa envelope protein domain III Japanese encephalitis virus JEVEDIII model demonstrate low immunogenicity E coli produced protein effectively overcome employing solubilitycontrolling peptide tag SCPtag composed five isoleucine C5I E coliproduced JEVEDIII oligomerized 100 nm Rh soluble oligomers upon attachment C5Itag whereas untagged JEVEDIII remained monomeric Rh ∼ 19 nm C5Itag significantly enhanced antiJEV EDIII IgG titers evidenced ELISA increased population memory cell spleen assessed flow cytometry notably C5Itagged JEVEDIII elicited neutralizing antibodies confirmed FRNTsub50sub neutralization assay using live JEV finding suggest oligomerization via SCPtagging offer promising adjuvantfree approach producing neutralizing antibody longterm cell memory paving way developing E coli produced protein domainbased vaccines",
        "mesh_terms": [
            "Encephalitis Virus, Japanese",
            "Antibodies, Neutralizing",
            "Escherichia coli",
            "Animals",
            "Viral Envelope Proteins",
            "Antibodies, Viral",
            "Encephalitis, Japanese",
            "Japanese Encephalitis Vaccines",
            "Mice",
            "Solubility",
            "Female",
            "Mice, Inbred BALB C",
            "Immunoglobulin G",
            "Recombinant Proteins",
            "Peptides",
            "Protein Domains"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40267616/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40266130",
        "title": "Navigating the Complexities of HIV Vaccine Development: Lessons from the Mosaico Trial and Next-Generation Development Strategies.",
        "abstract": "bBackgroundObjectivesb development effective HIV vaccine faced persistent challenges evidenced recent discontinuation Mosaico phase 3 trial study aim critically examine obstacle encountered HIV vaccine development focus Mosaico trial tested Ad26Mos4HIV vaccine among 3900 participant across multiple countries also explore emerging vaccine technology potential overcoming challenges reflecting lesson previous trial inform future strategies bMethodsb reviewed Mosaico trials approach involved testing efficacy Ad26Mos4HIV vaccine compared outcome Mosaico trial major HIV vaccine trials including HVTN 702 Imbokodo RV144 explored limitation immune response elicited Mosaico vaccine review focused generation broadly neutralizing antibody bNAbs challenge related antigenic diversity Bcell engagement Emerging vaccine technologies viruslike particle VLPs nanoparticles SOSIP trimers mRNA platforms also analysed scalability immune durability potential advance HIV vaccine development bResultsb Mosaico trial discontinued due insufficient efficacy reducing HIV acquisition primarily due inability vaccine induce bNAbs crucial targeting diverse HIV1 strains major challenge inadequate engagement germline Bcell precursors compounded antigenic diversity virus analysis showed emerging vaccine platforms VLPs nanoparticles SOSIP trimers mRNAbased approaches hold promise present challenge related scalability durability immune responses role cell adjuvant enhancing vaccine efficacy also highlighted critical integrating humoral cellular immunity bConclusionsb Mosaico trial well major HIV vaccine trials underscore need multipronged approach incorporates antibody Tcell response tackle complexity HIV1 Future effort HIV vaccine development must focus inducing bNAbs generating robust Tcell responses utilizing scalable vaccine platforms integration artificial intelligence AI vaccine design offer new opportunity optimize immunogenic targets could significantly improve potential durable broad immune protection development successful HIV vaccine 2030 achievable relies leverage advanced technology including artificial intelligence innovation insight past trial data",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40266130/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40256633",
        "title": "Disease burden in inflammatory arthritis: an unsupervised machine learning approach of the COVAD-2 e-survey dataset.",
        "abstract": "comprehensively compare disease burden among patient RA PsA using PatientReported Outcome Measurement Information System PROMIS score identify distinct patient cluster based comorbidity profile PROMIS outcomes Data global COVID19 Vaccination Autoimmune Diseases COVAD 2 esurvey analysed Patients RA PsA undergoing treatment DMARDs included PROMIS score global physical health global mental health fatigue 4a physical function short form 10a comorbidities variable compared among three groups stratified disease activity status Unsupervised hierarchical clustering eXtreme Gradient Boosting feature importance analysis performed identify patient subgroup based comorbidity profile PROMIS outcomes study included 2561 patient 1907 RA 311 PsA 343 AS adjusting demographic factors significant difference PROMIS score observed among three groups regardless disease activity status Clustering analysis identified four distinct patient groups low burden comorbid PsAAS low burden depression highburden RA Feature importance analysis revealed PROMIS global physical health strongest determinant cluster assignment followed depression diagnosis comorbid PsAAS highburden RA cluster showed higher prevalence comorbidities 5647 697 respectively depression 4118 4167 respectively along poorer PROMIS outcomes Disease burden inflammatory arthritis determined complex interplay factors physical health status depression playing crucial roles identification distinct patient cluster suggests need paradigm shift towards integrated care approach equally emphasize physical mental health regardless underlying diagnosis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40256633/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40253094",
        "title": "Finalising the WHO Pandemic Agreement for a safer future.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40253094/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40252689",
        "title": "The validity of test-negative design for assessment of typhoid conjugate vaccine protection: comparison of estimates by different study designs using data from a cluster-randomised controlled trial.",
        "abstract": "Typhoid fever remains substantial public health challenge lowincome middleincome countries 2023 typhoid conjugate vaccine TCVs introduced six country globally 50 million dos distributed TCVs deployed need observational study assess vaccine effectiveness field aimed evaluate validity different observational study design estimating vaccine protection compared different observational experimental study design assessing vaccine effectiveness reanalysing data TyVAC Bangladesh trial participantblinded observerblinded clusterrandomised controlled trial done Mirpur Dhaka Bangladesh 150 geographical cluster randomly assigned 11 receive either TCV Japanese encephalitis vaccine Eligible child aged 9 month 15 year offered single dose vaccine randomly assigned cluster residence baseline vaccination done April 15 May 15 2018 compared estimate vaccine effectiveness clusterrandomised controlled trial analysiswhich assessed risk bloodcultureconfirmed typhoid fever among recipient TCV versus recipient Japanese encephalitis vaccinewith estimate cohort study testnegative casecontrol study design TND analyses compared recipient TCV nonvaccinees 75 geographical cluster TCV administered conducted negativecontrol exposure NCE negativecontrol outcome NCO analysis bias indicators 41 344 67 62 025 ageeligible child study area received TCV Japanese encephalitis vaccine baseline vaccination campaign Among 62 025 ageeligible children 5582 bloodculture specimen collected passive surveillance including 2546 46 specimen 75 TCV clusters estimated vaccine efficacy 89 95 CI 8193 clusterrandomised controlled trial analysis 79 7086 cohort design 88 7993 TND pannegatives used testnegative controls 90 7596 TND specimen positive pathogen Salmonella enterica serotype Typhi used testnegative controls Using NCE analysis Japanese encephalitis vaccination associated increased risk typhoid fever compared nonvaccinees 75 Japanese encephalitis cluster cohort design incidence rate ratio 1·98 95 CI 1·562·52 significant association Japanese encephalitis vaccination typhoid fever found TND Similarly increased risk nontyphoid infection observed cohort NCO analysis comparing vaccinee nonvaccinees Japanese encephalitis vaccine cluster TCV clusters TND NCO analyses finding suggests TND provides reliable estimate TCV effectiveness whereas cohort design bias vaccine effectiveness estimates possibly due unmeasured confounding effects healthcareseeking behaviours NCE NCO approach useful tool identifying biases Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Humans",
            "Typhoid-Paratyphoid Vaccines",
            "Typhoid Fever",
            "Bangladesh",
            "Infant",
            "Child",
            "Child, Preschool",
            "Vaccines, Conjugate",
            "Male",
            "Adolescent",
            "Female",
            "Research Design",
            "Vaccine Efficacy",
            "Japanese Encephalitis Vaccines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40252689/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40247005",
        "title": "Functional T cell response to COVID-19 vaccination with or without natural infection with SARS-CoV-2 in adults and children.",
        "abstract": "Severe COVID19 rare child suggesting difference immune response child adults Limited information available cellular immunity modulated COVID19 vaccination prior infection whether differentially modulated child compared adults Here aimed compare COVID19 vaccineinduced functional cell response adult child without previous SARSCoV2 infection Adults 1845 years n  45 child 510 years n  51 received PfizerBioNTech COVID19 vaccine remained unvaccinated previously infected SARSCoV2 selected two crosssectional SARSCoV2 serosurveillance study conducted Bangladesh Plasma nucleocapsid Nspecific antibody measured electrochemiluminescence immunoassay IFNγ perforin granzyme B secreting cell assessed using ELISpot assay Vaccination adult without previous infection induced higher frequency IFNγ granzyme B secreting lymphocyte compared unvaccinated adults increased IFNγ expression vaccinated children Previous infection increased IFNγ response unvaccinated adult only Unvaccinated child showed higher granzyme B expression compared adult irrespective infection status vaccinated individuals prior infection induced perforin expression adult children Children showed slightly different functional cell response adult response COVID19 vaccination infection mRNA vaccination provided higher IFNγ response adult children induced cytotoxic lymphocyte CTL response adult only Future study may evaluate impact type COVID19 vaccine functional cell immunity child confirm findings",
        "mesh_terms": [
            "Humans",
            "Child",
            "Adult",
            "COVID-19",
            "Adolescent",
            "Male",
            "SARS-CoV-2",
            "Child, Preschool",
            "Middle Aged",
            "Female",
            "Young Adult",
            "Interferon-gamma",
            "T-Lymphocytes",
            "COVID-19 Vaccines",
            "Granzymes",
            "Antibodies, Viral",
            "Vaccination",
            "Cross-Sectional Studies",
            "Immunity, Cellular",
            "Perforin",
            "Bangladesh"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40247005/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40239175",
        "title": "Optimal control analysis for the transmission of Nipah infection with imperfect vaccination.",
        "abstract": "paper present innovative mathematical model assessing dynamic optimal control Nipah virus NiV imperfect vaccination model formulation considers transmission contaminated food humantohuman contacts also incorporates potential virus transmission contact deceased body infected NiV Initially NiV model assessed theoretically identifying three distinct equilibrium states NiVendemic equilibrium state NiVfree equilibrium state equilibrium state involving infected flying foxes Furthermore stability result model case constant control thoroughly analyzed NiVfree equilibrium parameter model estimated based infected case documented Bangladesh 2001 2017 perform sensitivity analysis determine influential parameter formulate effective timedependent controls Numerical simulation indicate optimal course action eradicating disease provide comparative analysis controlling infection constant timevarying interventions simulation confirms implementation timevarying intervention effective minimizing disease incidence",
        "mesh_terms": [
            "Henipavirus Infections",
            "Nipah Virus",
            "Humans",
            "Animals",
            "Vaccination",
            "Bangladesh",
            "Models, Theoretical",
            "Computer Simulation"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40239175/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40230444",
        "title": "Changes in enteric fever trends during the COVID-19 pandemic from the Surveillance for Enteric Fever in Asia Project: a cross-sectional study.",
        "abstract": "Surveillance Enteric Fever Asia Project SEAP conducted blood culture surveillance iSalmonella entericai serotype Typhi iSi Typhi Paratyphi iSi Paratyphi provide evidence base prevention control measure Bangladesh Nepal Pakistan October 2020 September 2022 conducted prospective clinical surveillance retrospective laboratory surveillance health facility Dhaka Bangladesh Kathmandu Kavrepalanchok Nepal Karachi Pakistan Patients eligible outpatient three day fever last week Nepal Pakistan inpatient eligible suspected confirmed enteric fever Bangladesh inpatient confirmed enteric fever enrolled Patients blood cultureconfirmed enteric fever identified hospital laboratory laboratory network site also enrolled Patients completed interview medical record reviewed abstracted enrolled patient blood culture performed Antibiograms performed characterize drug sensitivity summarized data descriptively total 17593 patient enrolled 19 facilities these 8410 patient cultureconfirmed enteric fever Case count country decreased early stage COVID19 pandemic increased time Bangladesh Pakistan Case count remained low throughout study period Nepal countries typhoid common paratyphoid proportion paratyphoid case ranged 84 Pakistan 16 Nepal Extensively drugresistant typhoid common Pakistan 69 detected Bangladesh Nepal Cases enteric fever decreased COVID19 pandemic though clear much decrease relates true change transmission versus healthseeking behavior project funded Gates Foundation INV008335",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40230444/",
        "source_type": "Bangladesh-specific"
    }
]